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ABSTRACT  
Muslims fast one month each year during the month of Ramadan. Many studies 
have been conducted on fasting during the month of Ramadan; however, their 
results were varied. Furthermore, few studies have been conducted on hormones 
levels during Ramadan and these studies had vastly inconsistent results. It is 
important to note that none of these studies controlled or even monitored physical 
activity and food intake. Purpose: The purpose of this study is to examine the 
effect of fasting during the month of Ramadan on anthropometric and blood 
variables. This study will determine if intermittent fasting will affect body 
composition, blood lipid profile, glucose, blood proteins and hormones. Methods: 
eight healthy athlete males aged (21.75± 2.05 years, 66.73±7.51 kg, 
170.68±5.21cm) participated in this study. The subjects were randomly selected 
from a first division Saudi Soccer League (Raka Soccer League). Weight, height 
and body composition of all subjects were recorded at baseline one day before 
Ramadan (D1), after ten days of fasting Ramadan (D10) and twenty-eight days of 
fasting Ramadan (D28).  Blood was collected and then analyzed. Physical 
activities and food intake were measured. All data was analyzed using 1x3 
repeated measures ANOVA (p< .05). Results: There was significant decrease in 
body mass (D1= 66.73 kg, D10= 66.73 kg and D28= 65.53 kg) and Lean body 
mass (D1= 50.51 kg, D10= 50.46 kg and D28= 49.46 kg) comparing the end of 
Ramadan with baseline and day 10 of intermittent fasting whereas they were 
almost identical at the baseline and Day 10 of Ramadan. There was no significant 
difference in data of Body Fat percentage. Physical activity, Vigorous activity and 
Moderate activity were significantly decrease at Day 10 and Day 28 of Ramadan. 
Total cholesterol, Triglycerides, LDL, HDL and VLDL did not show significant 
differences. However, the ratio of LDL to HDL was significantly increased at Day 
10 (p= 0.021) and at the end of fasting Ramadan (p= 0.004) compare to baseline. 
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Energy intake showed no significant differences overall across the three times of 
testing. However, the percentage which recommended dietary allowances of 
calories from protein showed significant decrease at Day 10 and Day 28 of 
Ramadan compare to the baseline (D1=17.57 %, D10 =12.50 % and D28 =11.35 
%). In addition, the percentage of calories from carbohydrate showed significant 
increase at Day 10 and Day 28 of Ramadan compare to the baseline (D1 =47.79 
%, D10 =59.01 % and D28 =57.89 %). Whereas, there were no significant 
changes in calories from fat. Fasted Glucose levels were significantly increased at 
D 10 but not at the end of Ramadan compare to the Pre-Ramadan p=0.001. 
Insulin and Cortisol did not change significantly at all measures. However, 
Glucagon decrease significantly after ten days of intermittent fasting and returned 
back closer to the Pre-Ramadan at the end of Ramadan. In addition, Albumin 
levels were significantly lower at Day 10 and Day 28 of Ramadan compare to 
baseline; however, Albumin levels were still within normal/health range. 
Conclusion: These results show the level of physical activity and food intake are 
major contributing factors on the reduction in body weight specifically the lean 
body mass. Overall, these findings indicate no health risk for fasting during the 
month of Ramadan. 
 
Key Words:  Ramadan, Intermittent fasting, Lipid profiles, Anthropometrics, 
hormones 
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ABBREVIATIONS 
 
A Activity  
 
AR Test was taken after Ramadan 
 
BW Body Weight  
 
CC% Percentage of Calories from Carbohydrate 
 
CP% Percentage of Calories from Protein 
 
CF% Percentage of Calories from Fat 
 
F Subjects were female 
 
F,M   Subjects were female and male 
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LDL Low density lipoprotein 
 
LDL/HDL Ration of LDL to HDL 
 
M Subjects were male 
 
nW Subjects were normal 
   
oW Subjects were overweight 
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VLDL Very low density lipoprotein 
 
1 
 
 CHAPTER I 
INTRODUCTION 
 Ramadan is the ninth lunar month in the Islamic calendar and Muslims all 
over the world fast each day of this month from sunset to sunrise. All adults 
participate with the exception of those who cannot i.e., persons that are traveling, 
menstruating, pregnant or nursing women, and others with a medical condition 
that would preclude fasting. During fasting, Muslims abstain from eating, 
drinking and sexual encounter. 
In 2012 was the first time that Muslim athletes competed in the Olympic 
games during Ramadan; could that cause a major disadvantage for these athletes? 
Research on the effect of fasting Ramadan on athletic performance will be the 
subject of major scientific interest in the future.  
Several studies have been conducted on the effect of fasting the month of 
Ramadan on body weight, Glucose levels, and hormone levels. A few studies 
showed either an increase (Forst and Priani 1987, Nagra et al 1998, Meckel et al 
2008) or no changes in body weight during the month of Ramadan (Lamari-
Senhadji et al 2009); but most studies show that fasting during Ramadan reduced 
body weight (Muazzam and Khaleque 1959, Fedail et al 1982, Husain et al 1987, 
Sweileh et al 1992, Afrasiobi et al 2002, Rahman et al 2004, Dewanti et al 2006, 
Bouhlel et al 2008, Abedelmalek et al 2011, Trabelsi et al 2012). A study by 
Leiper and others (2003); believed these body mass losses were mainly due to a 
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decrease of glycogen-bound water stores, in addition to a loss in body tissue 
specifically muscle mass.   
Studies by Nagra et al (1998), Sulieman et al (1982), Sarraf-Zadegan et al 
(2000), Halack et al (1988), Aldouni et al (1997), Temizhan et al (2000), Dowod 
Tahm (2004), and  Ziaee V et al (2006) reported that there was a significant 
decrease in LDL cholesterol while a significant increase in HDL cholesterol were 
reported by Maslos et al (1993), Aldouni et al (1997), Temizhan et al (2000), 
Afrasiabi et al (2002), and Rahman et al (2004). High blood cholesterol has long 
been considered a health factor in cardiovascular disease. These studies show that 
fasting during Ramadan may help to reduce the risks of CVD.  
A few studies have shown the effect of fasting on Ramadan in relationship 
to blood Glucose levels. Muazzam and Khaleque (1959), Aldouni et al (1997), 
Larijani et al (2003) Rahman et al 2004),  Malhotra et al (1989) , Nomani et al 
(1989) and Ziaee Vetal (2006) reported that Glucose levels show significant 
decrease in blood Glucose at the end of the month of Ramadan. While Temizhan 
et al (2000) reported a significant increase in blood Glucose at the end of the 
month of Ramadan.  
The inconsistency in the results of previous studies might be due to lack of 
control in the type and amount of food that was consumed by the subjects. The 
subjects could easily have consumed varying amounts of calories between these 
two measurements. A reliable study would be one that takes into consideration 
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not only this factor, but the factor of physical activity in relation to the subjects as 
well. Thus, there is a need for a study that will investigate the effects of fasting 
over a period of 14 to 16 hours each day for one month. Furthermore, this study 
will examine the effects of physical activity during fasting Ramadan. 
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1.1 Statement of the problem  
  Many studies have been conducted on fasting during the month of 
Ramadan. However, their results were varied and highly inconsistent. Most of the 
studies during Ramadan reported a reduction in body weight. Other studies found 
that body weight increased or was maintained at a Pre-Ramadan level. 
Furthermore, other studies looked at the effect of fasting during Ramadan on 
cholesterol and high and low-density lipoproteins levels and have also shown 
variances. Few studies have been conducted on hormone levels during Ramadan 
and these studies had vastly inconsistent results. Also, it is important to note that 
none of these studies controlled food intake with physical activity.  
Thus, there is a need for a study, which will consider the amount and type 
of food intake with physical activity. This study will investigate whether fasting 
14 to 16 hours during the day will affect the maintenance of anthropometric 
measurements, as well as the levels of lipids, proteins, Glucose and hormones. 
This study may also show if the level of physical activity is major contributing 
factors to the values in each of these areas during the month of Ramadan.  
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1.2  Hypothesis  
Many studies on body weight and blood variables have been conducted 
relating to fasting during the month of Ramadan. The results have been varied and 
inconsistent, possibly due to the differences in the procedures and the methods 
that were used. Most of the studies did not control the food intake and physical 
activity during fasting, this maybe the major factor affecting previous studies and 
their results.  
 
The hypotheses of this investigation:  
 
- The first hypothesis of this investigation is that the amount and type 
of food intake with physical activity levels will affect body weight 
and body fat significantly during fasting the month of Ramadan.  
 
- The second hypothesis of this investigation is that the amount and 
type of food intake with physical activity levels will affect the lipid 
profile, Glucose, blood proteins and hormones significantly during 
fasting the month of Ramadan.   
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1.3 Significant of the study  
The purpose of this study is to investigate the physiological and metabolic 
effects in the human body as related to fasting during the month of Ramadan. 
Each participating subject will have Glucose, Insulin, Glucagon, Cortisol, 
Albumin, and serum total protein levels as well as lipid profile values along with 
Anthropometric measurements evaluated during the month long intermittent 
fasting. This study may also show if the level of physical activity and food intake 
are major contributing factors on these variables.  
Information collected during this study may help to show that people who 
fast during the month of Ramadan can fast for an extended period without 
harmful physiological or metabolic effects. This study will also increase the level 
of awareness related to fasting and another significant aspect of this study is that it 
may show a more beneficial way of fasting for religious as well as health reasons.  
This study has the potential to have far reaching effects, not only within 
the scientific community as related to Muslims, but within every aspect of the 
medical community, such as a decrease in cardiovascular risk and better control 
for diabetic patients. A study with the documentation of physical activity while 
fasting could provide valuable information to the Muslims as well as every human 
being in the world who decides to utilize a fast for reasons of health. 
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CHAPTER II 
REVIEW OF LITERATURE 
 
2.1- Body weight and body fat during fasting Ramadan  
During the month of Ramadan, Muslims fast from sunrise to sunset, 
approximately 14 to 16 hours each day. However, they do eat and drink during the 
remaining hours. The effects of fasting during the month of Ramadan on body 
weight and body fat have been studied with inconsistent results. The majority of 
the studies conducted and published from 1959-2012 are related to body weight. 
Little research and even fewer articles have been written concerning body fat in 
relationship to the fast of Ramadan. A few studies however, show that fasting 
during Ramadan significantly reduced body weight and or body fat (Table 1-Body 
Fat and Table 2-Body Weight). Studies by Maislos et al, 1993 and Beltaifa et al, 
2002 reported non-significant changes in body weight. It is important to note that 
neither of these studies contained to body fat measurement.  
Forst and Pirani (1987) showed a significant increase of 3680kcal or a 
51.7% in caloric intake and a notable loss from 60.3kg to 58.9kg or a 2.38% 
decrease in body weight during the month of Ramadan. Reflectively, this weight 
loss could conceivably be due to increased physical activity. However, no 
documentation of physical activity was measured in this study. Two other studies 
examined caloric intake as well. Decreases in caloric intake were noted Khan and 
8 
 
Khattak, 2002 and Angel and Schwartz, 1974, 3.8% and 4.51% found 18.14% and 
30.44% with decreases in body weight respectively. 
A study conducted on Muslim women found that their body weight and fat 
mass did not change significantly. Also, they found the daily food intake pre-and 
post-Ramadan did not change (El Ati et al, 1995). A study on men by Meckel in 
2008 showed that while the intensity of the physical activity decreased 
significantly there was no major difference in either body weight or in caloric 
intake during Ramadan.  
A study of seven male subjects by Angel and Schwartz, 1974 revealed that 
daily caloric intake significantly decreased during Ramadan. The mean body 
weight among the seven males decreased significantly from 72.3kg to 69.6kg, a 
total of 3.32% reduction in body weight. Another study conducted on 12 men and 
9 females showed a reduction in body weight along with a decreased food intake 
in both genders. The females exhibited a 6.41% reduction in body weight, 
dropping from a mean weight 49.9kg to 46.7kg while the males showed a 
reduction of 4.04% going from a mean of 62.9kg to 60.3kg. Pre-and post-
Ramadan Anthropometric variables also showed no significant changes (Husian 
1987).  
Two other studies, one conducted on women and the other on men 
revealed significant correlations between decreased caloric intake and loss in 
body weight. The study on 12 athletic females during Ramadan revealed 
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significant decreases in body weight and body mass index (BMI) related to a 
diminished caloric intake. A mean body weight loss from 56.41kg to 54.78kg, a 
drop of 2.98% and a loss of 3.02% in BMI were documented (Memari, 2011).  
The study consisting of nine men showed evidence of body weight loss with a 
decreased food intake. A mean body weight decrease from 74.00kg to 71.50kg, a 
3.50% loss was documented (Abedelmalek et al, 2011).  
A study performed by Takruri (1989) examined the various weight 
categories i.e. normal weight, overweight, and underweight. The researcher found 
that the female’s weight loss was less than the males in all weight categories 
probably because females have a higher body fat content. Thus, certain types of 
medical conditions such as obesity could possibly benefit from this type of 
fasting.   
A study of 19 physically active men by Trabelsi et al stated that though the 
subject’s caloric intake did not change the subject demonstrated a significant 
reduction in body weight and body fat. Interestingly, a significant reduction in 
water, 4.0L down to 3.3L was noted (Trabelsi et al, 2012). These studies show the 
influence that caloric intake has on individuals when undertaking an altered diet 
as well as altered meal schedules. It is important to note that none of these studies 
showed any correlation between body weight and the level of physical activity 
during the month of Ramadan. We hypothesize that the inconsistencies in testing 
results may be due to the type of food eaten as well as the amount of caloric 
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intake. In addition, the type and the intensity of the PA each subject participates in 
may be a prime factor.  
A study from Hallak and Nomani (1988) found that during the last two 
weeks of Ramadan fasting (RF), when the subjects increased energy intake by 8 
% (from 1696 kcal/day to 1834 kcal/day) while being on a high-fat diet, there was 
no significant difference in body weights during this time period. Pre-Ramadan 
each subject consumed 2275 kcal per day. During the first two weeks of the study 
with reduction in caloric intake there was a significant decrease of 2.9% in body 
weight.  
Biologists Viqul and Chow (2006) investigated patterns in the food intake 
of 29 subjects for one year in correlation with body mass index (BMI). Their 
findings showed the mean energy intake was less significant relating to BMI, but 
had a greater significance related to mean body weight.  
Energy intake versus energy expenditure combined with dietary 
requirements play major roles in body-weight loss and/or control. In order for 
weight control maintenance to be achieved the energy expenditure must be equal 
to the energy intake. For weight loss to occur energy intake must be less than 
energy expenditure to result in body weight loss. Weight loss is also connected to 
high levels of physical activity, associated with various types of work, especially 
those that require constant muscle contraction and relaxation. Clearly, these types 
of physical activities require high-energy intake.  Therefore, physical activity has 
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a major impact on the energy expenditure and energy balance in any 24-hour 
period (Tappy et al, 2003). An experimental 3-year, study was conducted by Cox 
with others in 2007, to determine the relationship between weight maintenance, 
the role of physical activity and the amount of energy intake. Utilizing a program 
of moderate and vigorous activity each day along with each person’s individual 
diet they concluded the level of physical activity may affect the amount of energy 
intake required to maintain body weight. Another non-Ramadan study lasting for 
12 weeks (Hagan, et al., 1986) compared the amount of weight lost and body fat 
reduction in obese females and males; through diet with exercise, diet alone, 
exercise alone and the last group as a sedentary control group. The diet was 
controlled at 1200 kcal per day and the exercise portion of the study consisted of a 
30-minute walk or run 5 times per week. The diet-exercise group with the diet 
only group had a greater body weight and body fat reduction than either the 
exercise only or sedentary groups. This study clearly illustrates that the low 
caloric intake and the level of physical activity affect weight loss.  
 In conclusion, there have been many studies conducted on the fast of 
Ramadan related to body weight. The inconsistencies of previous studies appears 
to have a direct correlation to the fact that the majority of the studies do not 
control the amount of food intake; nor do they control the level of physical 
activity between these two measurements. Moreover, additional research needs to 
be conducted to not only further investigate the fast of Ramadan in relationship to 
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body weight, but the inclusion and consideration of the level of physical activity 
along with the amount and type of food intake.  
 
Table 1: Show the effect of fasting during the month of Ramadan on body fat 
(BF) 
Baseline BF 
(%)  
Ramadan BF 
(%)  
% Changes  Reference   
16.70 F16 16.20 -2.99 El Ati et al (1995) 
23.90 F 46 22.40 -6.28 Kassab et al (2004) 
24.90 F 57 24.50 -1.61 Al-hourani and Atoum (2007) 
16.40 M9 16.10 -1.83* Bouhlel et al (2008) 
10.00 M8 9.40 -6.00 Chennaoui et al (2009) 
19.40 M18 18.20 -6.19* Trabelsi et al (2011) 
* Significant; Baseline would be the point where the subjects were not fasting the month of 
Ramadan; Ramadan would be the point where the test was performed during the last week of 
Ramadan; AR the test of body weight was taken after Ramadan; BW body weight; M the 
subjects were male; F the subjects were female; F,M  the subjects were female and male;  uW the 
subjects were underweight. oW the subjects were overweight;  nW the subjects were normal; S 
Sedentary; A Activity   
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Table 2-1: Show the effect of fasting during the month of Ramadan on body 
weight.  
Baseline BW 
(kg)  
Ramadan BW 
(kg)  
% Changes  Reference   
55.4 F,M13  54 -2.53 Muazzam and Khaleque (1959)  
72.3 M7  69.9 -3.32 Angle and Schwartz (1974)  
69.5 F4, M20  67.7 -2.59*  Fedail et al (1982)  
49.9 F9  46.7 -6.41*  Husain et al (1987)  
62.9 M12  60.36 -4.04*  Husain et al (1987)  
58.9 F2,M13  60.3 2.38*  Forst and priani (1987)  
66.2 M16  63.8 -3.63*  Hallack et al (1988)  
oW76.8F25,M50   72.18 -6.02*  Hamaed Takruri (1989)  
nW62.01F14,M24  60.02 -3.21*  Hamaed Takruri (1989)  
uW54.17F8,M16  53.53 -1.18*  Hamaed Takruri (1989)  
67.61F47,M90  65.51 -3.11*  Hamaed Takruri (1989)  
60.5M12,F10  59.8 -1.16*  Mafauzy et al. (1990)  
72.1F1,M7  70.18 -2.66*  Sweileh et al (1992)  
4WAR68.2F8,M16  68 -0.29 Maislos et al (1993)  
59.3F16  58.9 -0.67 El Ati et al (1995)  
69.61M32  67.83 -2.56*  Adlouni et al. (1997)  
51.9F26  52.6 1.35 Nagra et al (1998)  
S77.4M7  76.5 -1.16 Ramadan et al (1999)  
A71.5M6  70.5 -1.4 Ramadan et al (1999)  
86.7M22 84.4 -2.65*  Afrasiobi et al. (2002)  
79.8M16  78.6 -1.5 Afrasiobi et al. (2002)  
66.3M20  66.2 -0.15 beltaifa et al (2002)  
80.8M,F10  77.7 -3.84*  Khan and Khattak (2002)  
56M38   54 -3.57 Dadeya et al. (2002)  
64.05 M 20  62.07 -3.09*  Rahman et al (2004)  
80.8 F 46  80.1 -0.87 Kassab et al. (2004)  
68.67F16,M18  68.64 -0.04 Yucel et al (2004)  
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Table 2-2: Show the effect of fasting during the month of Ramadan on body 
weight.  
Baseline BW 
(kg)  
Ramadan BW 
(kg)  
% Changes  Reference   
62.4F39, M41  61.2 -1.92* Ziaee et al. (2006)  
55.7 F39  54.6 -1.97* Ziaee et al. (2006)  
68.7M41  67.5 -1.75* Ziaee et al (2006)  
64.5 M37  63 -2.33*  Dewanti et al (2006)  
57.50 F57 56.90 -1.04* Al-Hourani and Atoum (2007 
80.40M9 78.60 -2.24* Bouhlel et al (2008) 
70.50 F5,M9 69.10 -1.99 Ibrahim et al (2008) 
62.50 M19 62.80 0.48 Meckel et al (2008) 
80.69 M62 78.73 -2.43* Shariatpanahi et al (2008) 
67.10 M8 65.60 -2.24 Chennaoui et al (2009) 
53.00 F24 52.00 -1.89 Lamri-Senhadji et al (2009) 
70.00 M22 70.00 0.00 Lamri-Senhadji et al (2009) 
74.00 M9 71.50 -3.38* Abedelmalek et al (2011) 
70.60 M14BI 68.50 -2.97* Kordi et al (2011) 
68.00 M22AI 66.30 -2.50* Kordi et al (2011) 
56.41 F12 54.78 -2.89* Memari et al (2011) 
79.20 M19 77.70 -1.89* Trabelsi et al (2012 
* Significant; Baseline would be the point where the subjects were not fasting the month of 
Ramadan; Ramadan would be the point where the test was performed during the last week of 
Ramadan; AR the test of body weight was taken after Ramadan; BW body weight; M the 
subjects were male; F the subjects were female; F,M  the subjects were female and male;  uW the 
subjects were underweight. oW the subjects were overweight;  nW the subjects were normal; S 
Sedentary; A Activity;   
BI 
Before Iftar; AI After Iafter.  
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2.2- Lipid profile and the fasting of Ramadan  
A Lipid Profile (LP) or Lipid Panel is a test that evaluates the levels of 
Total Cholesterol (TC), High-Density Lipoproteins (HDL), Low-Density 
Lipoproteins (LDL), and Triglycerides (TG) in serum blood. These levels are vital 
in the screening and monitoring of multiple medical conditions, i.e., 
cardiovascular disease (CVD), thyroid disease, liver disease, renal disease, along 
with various metabolic disorders such as Diabetes Mellitus (DM), (Fischbach, 
1998). The levels of a lipid profile frequently evaluate the effectiveness of dietary 
and medication concerns. Many factors contribute to the deviations found in these 
levels. These variances have been traced back to metabolic diseases, CVD, 
pregnancy, thyroid and liver disease, and medication that the person is taking as 
well as persons who fast for either short or extended periods of time. 
During Ramadan fasting the frequency and amount of caloric intake is 
decreased (Angel and Schwartz, 1974). Because of these dietary changes and the 
time requirement involved for fasting, the month of Ramadan has been studied 
multiple times, but with a diversity of results related to each aspect of the Lipid 
Profile (LP). Many studies showed substantial decreases in total cholesterol levels 
whereas other investigations documented significant increases in serum blood TC 
levels during the month of Ramadan.  
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Asgary et al, 2000 and Aldouni et al, 1997 in studies conducted on both 
genders showed significant decreases in TC, 7.30% and 7.93%, respectively. 
While the greatest decrease in TC was 10.04% found by Temizhan et al in 2000.  
Several studies conducted on both genders showed noteworthy elevations 
in TC concentrations. Fedial et al 1982 saw increases of 9.15% in TC levels. 
Barkia et al in 2011 recorded greater increases in TC levels of 13.64%. Another 
notable study conducted by Lamri-Senhadji et al in 2009-documented substantial 
elevations of TC in both genders with an increase in women of 13.83% and in 
men of 23.60%. Interestingly, the majority of the results obtained from the studies 
showed no significant changes in TC serum blood levels (Table 3). 
In summary, total cholesterol levels on serum blood obtained during 
Ramadan fasting were widely presented. A few studies showed marked decreases 
in TC serum levels as great as 10.04% others revealed elevated percentages as 
high as 23.60%. Although these percentage values were elevated, they remain 
within the normal/health range. Although, most studies reviewed did not separate 
decreased or increased percentages per gender those that did revealed diminished 
as well as elevated finding for both genders. Lamri-Senhadji et al and Barkia et al 
were in agreement with Aldouni et al, Asgary et al as well as Temizhan et al in 
their conclusion that the type and amount of caloric intake such as, increasing 
protein, carbohydrate and fat consumption play a major role in either increasing 
or decreasing total cholesterol levels. The frequencies of many small meals 
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instead of having one or two large meals were also considered as a viable 
contributing factor in lowering total cholesterol levels. 
Low-Density Lipoproteins known as “bad cholesterol” is another 
component of a Lipid Profile. Elevated levels within this are considered 
negatively from a medical aspect and have been associated with the increased risk 
of CVD, renal disease and various metabolic disorders. LDL levels have been 
reported in studies related to Ramadan fasting in a wide range of high and low 
percentages. Some studies looked at blood values from both genders separately, 
whereas others recorded a mean percentage covering both genders. In 2004 a 
study conducted on both genders recorded a mean LDL decrease of 6.49%. While 
a study comprised of 32 males conducted in 1997 recorded mean LDL decreases 
of 11.68% (Dowod Tahm, 2004 and Aldouni et al, 1997).  
Two other studies, Temezhan et al, 2000 and Lamri-Senhadji et al, 2009 
recorded significant changes in both genders but with opposite values per group. 
Temezhan showed decreases in mean LDL levels for women of 12.40% and men 
10.97%, whereas Lamri-Senhadji et al found decrease of 13.29% for women and 
32.16 % for men. 
Though a number of studies show decreases in LDL levels during 
Ramadan fast other studies show marked increases in the same blood values. 
Studies in 2006 and 2011 looked at lab values in each gender. Mean LDL blood 
value percentages were elevated in both studies, Ziaee et al, 2006 with an increase 
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of 3.82% and Barkia et al in 2011 with a mean increase of 20.69% (Ziaee et al, 
2006 and Barkia et al, 2011).  
A study showing one of the highest recorded increases, 24.89% found that 
the significant elevation of LDL could logically be related to the total caloric 
intake and the type of dietary fat consumed (Halack et al, 1988), (Table 5). A 
cholesterol study on non-fasting in 2001 found a strong relationship between the 
frequency of eating and the levels of TC and LDL. With an increased frequency 
of meals the serum levels of TC and LDL decrease (Titan et al, 2001).  
Interpretation of data varies somewhat per study. However, for the most 
part a consensus regarding the healthy influence of smaller, frequent meals versus 
one or two large meals appears to have been established. These smaller meals 
combined with the specific types of caloric intake such as increased carbohydrate 
and fat intake may well have a more direct and beneficial outcome in controlling 
LDL levels than one or two large meals during the Ramadan fast. Additionally, 
non-fasting study results support the conclusion that concentrations of low-
density lipoproteins as well as other components of a lipid profile, high-density 
lipoproteins, are linked to meal frequency. 
 High-density lipoproteins are usually considered as “good cholesterol” and 
contain positive reinforcing factors against various CVD. Increased levels of HDL 
are considered positive and advantageous from a medical viewpoint. 
Consequently, decreased levels of HDL can amplify a person’s health risk. A 
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study, divided into two phases, of sixteen healthy males had significantly 
decreased levels of HDL by the end of the four-week fast. During phase-one, the 
first two weeks of Ramadan, each subject consumed 77.1% of carbohydrates and 
8.8% of fat. Phase-two followed with caloric intake of 35% carbohydrates and 
51% of fat over the last two weeks of fasting. HDL levels at the end of phase one 
saw a decrease of 8.38%, at the end of phase two HDL levels had decreased to 
19.09% (Halack et al, 1988).  
Another study that considered energy intake and dietary fat consumption 
during fasting was Ziaee et al in 2006. He conducted a study on 80 men and 
women and documented a mean decrease in HDL levels of 9.00%.  
 Just as energy intake affects decreases in HDL concentrations it also 
greatly impacts increases in HDL levels. Rahman et al conducted an investigation 
using twenty healthy males. He reported mean HDL increases of 22.47% with an 
increased fat intake. Another researcher compared forty-six men and women and 
obtained mean concentration levels of HDL at a 19.34% increase for the women 
and a 16.84% increase for the men (Rahman et al, 2004 and Lamri-Senhadji et al, 
2009). 
Aldouni et al, 1997 and Maislos et al, 1993 both considered “feeding 
behavior” a vital factor in the increased HDL levels in their Ramadan study 
groups. Meal frequency and diet composition, increased protein and 
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carbohydrates with decreased fat intake, were also considered contributing 
aspects. Mean percentages of HDL levels were 14.30% and 32.01%, respectively.  
 The greatest HDL concentration percentage increase found was Bouhlel et 
al, 2008 during a study consisting of 9 well-trained male athletes. A recorded 
mean HDL of 56.48% was documented.( Table 5) 
The findings from these researchers support the concepts and correlations 
between LDL and HDL concentrations and energy intake. The type and amount 
of food consumed is also a direct link to serum cholesterol levels.  
The last component of a lipid profile is Triglycerides. Persons with high 
Triglyceride levels have been classified as high-risk individuals for CVD and 
various Endocrinopathies (Fischbach, 1998).  
 A study conducted by Ramadan et al in 1999 compared sedentary and 
active subject groups in relationship to the fast of Ramadan. The sedentary group 
(S), seven office workers, did not participate in any type of exercise program 
during fasting. The active group (A), also six office workers, performed a brisk 
exercise session of jogging or brisk walking for 30 to 60 minutes each day, 3 to 5 
times per week. The S group had mean TG reductions of 11.91% while the A 
group had reductions of 7.33%. (Table 6). Values found during this study showed 
that group S decreased their caloric intake in order to maintain their body weight. 
This change in dietary pattern caused a reduction in the serum levels of TG. On 
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the other hand, group A did not change or decrease their food intake, thus causing 
an elevation in their serum TG levels (Ramadan et al, 1999).  
Aldouni et al reported 30 % decreases in serum TG levels during Ramadan 
in 1997. His study found a substantial decline in these levels and was most likely 
related to the dietary pattern changes and the amount and type of fat consumed. 
The study also related a correlation between increased energy and the amount of 
carbohydrate intake. The study showing one of the highest recorded decreases in 
serum TG, 31.20% found that the significant absence of TG was related to but not 
limited by the replacement of fats to carbohydrates (Halack et al, 1988) 
Increases in serum TG were found in several studies. Ziaee et al in 2006 
evaluated TG levels in a mixed gender study of 80 subjects. The males showed a 
slight increase of 10.55% in serum TG levels. Interestingly, the females showed a 
very slight decrease of 4.39%. A study reviewed with the highest increase was 
Bouhlel et al in 2008. This study of nine males recorded a mean increase of serum 
TG level of 28.81%. 
In conclusion, the need for improved control over specific biochemical 
markers is apparent. Heart disease and diabetes are increasing throughout the 
world. If altering a dietary pattern as seen in these studies can control, elevate and 
lower these markers without major dietary and pharmacological changes, the 
medical community will gain vital knowledge (Fischbach, 1998; Venes, 2005). 
Significant declines in total cholesterol and triglyceride levels are most likely 
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related to the dietary pattern changes and the amount of fat intake noted during 
Ramadan. The increase in high-density lipids or “good cholesterol” may also be a 
by-product of the Ramadan fast.  
Multiple studies have found that several small frequent meals have a 
greater influence on lowering these specific laboratory values than values 
obtained after the subjects consumed one or two large meals. The physical 
activity each subject participated in combined with the type of diet consumed also 
seems to have played a major role in blood chemistry levels found in the studies.  
Rahman found that HDL concentrations increased while his subjects’ were 
consuming a high fat diet, these findings are in conflict with previous studies and 
nutrition’s acknowledged role in lipid profile concentrations. This investigation 
may explain that the type and amount of food intake combined with the level of 
physical activity may directly impact blood chemistry levels such as those related 
to a Lipid Profile.  
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Table 3-1: show the effect of fasting during the month of Ramadan on total 
cholesterol 
Baseline TC 
(mg/dl) 
Ramadan TC 
(mg/dl) 
% Changes Reference 
227M7 229 0.88 Angel and Schwartz (1974) 
164.69F4,M20 179.77 9.15* Fedail et al. (1982) 
186.30M16 189.9 1.93 Halack et al. (1988) 
216.11F10,M12 224.61 3.94 Mafauzy et al. (1990) 
150F8,M32 156 4.00 Maislos et al. (1993) 
178.61F16 194.07 8.66 El Ati et al. (1995) 
165.85M32 152.71 -7.93* Aldouni et al. (1997) 
S178.22M7 189.43 6.29 Ramadan et al. (1999) 
A207.60M6 204.12 -1.68 Ramadan et al. (1999) 
228.09F,M50 214.18 -6.1 Sarraf-Zadegan et al. (2000) 
226.09F,M50 209.59 -7.30* Asgary et al. (2000) 
198.7M25 183.5 -7.65* Temizhan et al. (2000) 
193.3F27 173.9 -10.04* Temizhan et al. (2000) 
247.10M22 245.6 -0.2 Afrasiabi et al. (2002) 
202.10M16 202.8 0.35 Afrasiabi et al. (2002) 
204.90F,M10 203.35 -0.75 Khan and Khattak (2002) 
168.40M20 165.15 -1.93 Rahman et al (2004) 
181.32F,M60 176.29 -2.77 Dowod Tahm (2004) 
170.49F46 177.06 3.85 Kassab et al. (2004) 
* Significant; Baseline would be the point where the subjects were not fasting the month of 
Ramadan; Ramadan would be the point where the test was performed during the last week of 
Ramadan; AR the test of body weight was taken after Ramadan; BW body weight; M the 
subjects were male; F the subjects were female; F,M  the subjects were female and male;  uW the 
subjects were underweight. oW the subjects were overweight;  nW the subjects were normal; S 
Sedentary; A Activity 
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Table 3-2: show the effect of fasting during the month of Ramadan on total 
cholesterol 
Baseline TC 
(mg/dl) 
Ramadan TC 
(mg/dl) 
% Changes Reference 
166.1M41 168.7 1.57 Ziaee V et al. (2006) 
170.7F39 171.5 0.47 Ziaee V et al. (2006) 
168.3F,M81 170 1.01 Ziaee V et al. (2006) 
150.77 M9 169.72 12.57 Bouhlel et al (2008) 
199.60 F5,M9 188.10 -5.76 Ibrahim et al (2008) 
204.12 F24 232.35 13.83* Lamri-Senhadji et al (2009) 
206.44 M22 255.16 23.60* Lamri-Senhadji et al (2009) 
170.10 F6,M19 193.30 13.64* Barkia et al (2011) 
150.77 M10 158.51 5.13 Trabelsi et al (2011) 
151.56 M19 157.73 4.07 Trabelsi et al (2012) 
* Significant; Baseline would be the point where the subjects were not fasting the month of 
Ramadan; Ramadan would be the point where the test was performed during the last week of 
Ramadan; AR the test of body weight was taken after Ramadan; BW body weight; M the 
subjects were male; F the subjects were female; F,M  the subjects were female and male;  uW the 
subjects were underweight. oW the subjects were overweight;  nW the subjects were normal; S 
Sedentary; A Activity 
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Table 4: show the effect of fasting the month of Ramadan on low-density 
lipoprotein (LDL).  
Baseline LDL 
(mg/dl)  
Ramadan LDL 
(mg/dl)  
% Changes  Reference 
94.40M16  117.9 24.89*  Halack et al. (1988)  
99.50F8,M16  97.5 -2.01 Maslos et al. (1993)  
112.50M32  99.36 -11.68*  Aldouni et al. (1997)  
114.90M25  102.3 -10.97*  Temizhan et al. (2000)  
121.00F27  106 -12.40*  Temizhan et al. (2000)  
8WAR138.40F,M50 140.72 1.68 Sarraf-Zadegan et al. (2000)  
148.00M22  144.2 -2.57 Afrasiabi et al. (2002)  
111.00M16  122.4 10.27 Afrasiabi et al. (2002)  
80.03F,M10  78.48 -1.93 Khan and Khattak (2002)  
119.07F,M60  111.34 -6.49*  Dowod Tahm (2004)  
114.90M41  119.6 4.09 Ziaee V et al. (2006)  
115.40F39  120.1 4.07 Ziaee V et al. (2006)  
115.20F,M80  119.6 3.82*  Ziaee V et al. (2006)  
98.97 F24 85.82 -13.29* Lamri-Senhadji et al (2009) 
110.56 M22 75.00 -32.16* Lamri-Senhadji et al (2009) 
112.11 F6,M19 135.31 20.69* Barkia et al (2011) 
95.10 M19 89.30 -6.10 Trabelsi et al (2012) 
* Significant; Baseline would be the point where the subjects were not fasting 
the month of Ramadan; Ramadan would be the point where the test was 
performed during the last week of Ramadan; AR the test of body weight was 
taken after Ramadan; BW body weight; M the subjects were male; F the 
subjects were female; F,M  the subjects were female and male;  uW the subjects 
were underweight oW the subjects were overweight;  nW the subjects were 
normal; S Sedentary; A Activity  
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Table 5: shows the effect of fasting during the month of Ramadan on high-density 
lipoprotein (HDL). 
Baseline HDL 
(mg/dl) 
Ramadan HDL 
(mg/dl) 
% Changes Reference 
72.80M16 58.9 -19.09* Halack et al. (1988) 
72.80 M16 66.70 8.38 Halack et al. (1988) 
27.80F8,M16 36.7 32.01* Maslos et al. (1993) 
35.18M32 40.21 14.30* Aldouni et al. (1997) 
8WAR42.14F,M50 41.75 -0.93 Sarraf-Zadegan et al. (2000) 
53.30M25 54.7 2.63* Temizhan et al. (2000) 
53.70F27 54.8 2.05* Temizhan et al. (2000) 
42.90M22 48 11.89* Afrasiabi et al. (2002) 
43.20M16 45 4.17 Afrasiabi et al. (2002) 
71.91F,M10 71.13 -1.08 Khan and Khattak (2002) 
38.14M20 46.71 22.47* Rahman et al (2004) 
36.10M41 32.4 -10.25* Ziaee V et al. (2006) 
44.10F39 40.8 -7.48 Ziaee V et al. (2006) 
40.00F,M80 36.4 -9.00* Ziaee V et al. (2006) 
41.75 M9 65.33 56.48* Bouhlel et al (2008) 
93.94 F24 112.11 19.34* Lamri-Senhadji et al (2009) 
75.77 M22 88.53 16.84* Lamri-Senhadji et al (2009) 
38.66 F6,M19 38.66 0.00 Barkia et al (2011) 
42.53 M10 54.12 27.25* Trabelsi et al (2011) 
42.91 M19 53.35 24.33* Trabelsi et al (2012) 
* Significant; Baseline would be the point where the subjects were not fasting the month of 
Ramadan; Ramadan would be the point where the test was performed during the last week of 
Ramadan; AR the test of body weight was taken after Ramadan; BW body weight; M the 
subjects were male; F the subjects were female; F,M  the subjects were female and male;  uW the 
subjects were underweight. oW the subjects were overweight;  nW the subjects were normal; S 
Sedentary; A Activity 
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Table 6: show the effect of fasting during the month of Ramadan on Triglycerides  
Baseline TG 
(mg/dl)  
Ramadan TG 
(mg/dl)  
% 
Changes  
Reference   
115.79 F4,M20 111.4 -3.79 Fedail et al. (1982)  
95.2 M16 65.5 -31.20* Halack et al. (1988)  
113.15 F8,M16 96.5 -14.71 Maslos et al. (1993)  
87.72 M32 61.4 -30.00* Aldouni et al. (1997)  
80.5 F,M26 92.5 14.91 Nagra et al (1998)  
169.29 S  M7 149.12 -11.91 Ramadan et al. (1999)  
131.57 A M6 121.93 -7.33 Ramadan et al. (1999)  
209 F,M50 193 -7.66* Asgary et al. (2000)  
150.6 M25 121.8 -19.12* Temizhan et al. (2000)  
92.8 F25 66.2 -28.66* Temizhan et al. (2000)  
260.4 M22 226.6 -12.98* Afrasiabi et al. (2002)  
235.7 M16 171.1 -27.41* Afrasiabi et al. (2002)  
119.29 F,M10 118.42 -0.73 Khan and Khattak (2002)  
146.66 M20 131.04 -10.65 Rahman et al (2004)  
116.66 F,M60 127.19 9.03 Dowod Tahm (2004)  
77.7 M41 85.9 10.55* Ziaee V et al. (2006)  
54.7 F39 52.3 -4.39 Ziaee V et al. (2006)  
66.6 F,M80 69.7 4.65 Ziaee V et al. (2006)  
51.75 M9 66.66 28.81* Bouhlel et al (2008) 
116.90 F5,M9 87.50 -25.15* Ibrahim et al (2008) 
58.77 F,M50 81.58 38.81* Lamri-Senhadji et al (2009) 
63.16 F,M50 60.52 -4.18* Lamri-Senhadji et al (2009) 
96.49 F6,M19 96.49 0.00 Barkia et al (2011) 
61.40 M10 70.17 14.28 Trabelsi et al (2011) 
60.52 M19 67.54 11.60 Trabelsi et al (2012) 
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2.3 Glucose, Creatinine and hormones levels during fasting Ramadan 
Due to the amount of time required for fasting, the multiple components 
relating to Ramadan fast has been extensively studied in diverse combinations 
with varied and vast results (i.e. weight loss, BMI, caloric intake, dehydration, 
lipid, Glucose and creatinine levels, etc). A Reliable data on the exploration of the 
effects of fasting on hormone levels, specifically, Insulin, Glucagon, and cortisol 
levels are scarcer or non-existent. 
Most metabolic and physiological functions in the human body derive its’ 
energy from Glucose. This makes the maintenance of blood Glucose levels one of 
the body’s highest priorities. The absorptive phase refers to the first couple of 
hours after a meal when Glucose is the principal source of energy for tissues. 
During time between meals, the post-absorptive phase, fatty acids become the 
main source of energy for the body (Smith, 2005). When blood Glucose levels are 
high, large amounts of Glucose are taken up and stored by the liver and muscle as 
glycogen; excluding periods of constrained dietary intake when carbohydrate 
intake is severely restricted. 
The main source of fuel for the brain is Glucose. The brain and central 
nervous system (CNS) uses approximately 150grams of carbohydrates per day. 
Any decrease in serum Glucose levels, which would include the state of fasting, 
initiates multiple body maintenance systems in order to increase serum 
concentrations of Glucose (Nelson and Cox, 2004). 
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A number of studies revealed nearly negligible percentage changes in 
Glucose levels in correlation to fasting of Ramadan. Asgary et al, 2000 and Nagra 
et al, 1998 conducted studies on both genders during Ramadan. Results showed 
only minimal percent changes in serum Glucose concentrations during fasting. 
Combined mean value changes were 92.57mg/dL dropping to 90.22mg/dL, a 
2.54% change and 84.10mg/dL dropping to 82.3mg/dL equaling a 2.14% change 
in serum blood Glucose levels, Asgary et al 2000 and Nagra et al 1998 
respectively (Table 7). 
A Ramadan study in 2002 focused on the effects of fasting on Glucose 
levels in ten healthy men.  Food and fluid intake were recorded before and during 
the first and fourth week of fasting. Blood samples were obtained prior to, and 
repeated in the second and fourth week of fasting.  Mean Glucose levels 
decreased from 82.15mg/dL to 79.63mg/dL, showing a minimal drop of 3.07%. 
(Khan and Khattak, 2002).  
 Minimal Glucose decreases continue with Adlouni et al’s study in 1997. 
They conducted a study on thirty-two healthy male subjects. Utilizing four serum 
blood samples taken at days 8, 15, 22 and 29 (last day of Ramadan); each subject 
provided his own baseline. Glycemic changes were significant with a decrease of 
14.1% (mean levels were 91.88mg/dL with a decrease to 78.91mg/dL) by day 29 
of Ramadan.   
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Several studies documented significant decreases in serum Glucose levels 
in connection to Ramadan fasting. A study from the Endocrinology & Metabolism 
Research Center in 2003 relating to both genders on fasting serum Glucose 
concentrations in healthy adults showed considerable percentage decreases in 
serum Glucose levels.  While dietary intake was not controlled, it was recorded 
through the use of a food frequency questionnaire on the first and fifteenth days of 
Ramadan.  After establishing a baseline for both genders, levels were examined 
on the fourteenth and twenty-eighth day of Ramadan. Following 14 days of 
fasting, female Glucose levels decreased from a mean of 89.7mg/dL (baseline) to 
a mean of 67.5mg/dL; this level further dropped to a mean serum level of 
65.7mg/dL at 28 days of fasting constituting a substantial decrease of 26.76%.   
Males during this same period of time showed mean levels as follows: 87.5mg/dL 
decreased to 81.1mg/dL followed by a substantial drop to 60.8mg/dL a 30.51% 
decrease in serum Glucose levels.  It is important to note, the caloric intake 
decreased for all participates and sleep patterns were altered during Ramadan 
(Larijani et al, 2003).  
Another investigation with noteworthy findings was conducted on thirteen 
healthy adults.  This study extended the number of blood samples for 
investigation to five; at one week prior to Ramadan (baseline), repeated on day 1, 
10, and day 28 of fasting. The final blood sample was obtained four weeks after 
completion of Ramadan.  The mean levels were 84.00mg/dL with a drop to 
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74.00mg/dL, an 11.90% decline in serum blood Glucose levels. (Muazzam and 
Khaleque, 1959) 
Increases in serum Glucose have also been included. It is important to note 
that the increases of Glucose we found where negligible in comparison to the 
decreases in Glucose during Ramadan fast. 
Studies showing insignificant increases were from Dowad (2004) with an 
increase of 0.54% (mean levels of 100.53mg/dL to 101.07mg/dL), the other study 
was by Mafauzy et al (1990) showing an elevation in Glucose levels of 1.87% 
(mean levels of 192.77mg/dL elevated to 196.37mg/dL).  The interesting aspect 
regarding this study is that it was conducted on twenty-two diabetic patients on 
oral hypoglycemic agents. Blood was drawn for serum Glucose levels just prior to 
the start of Ramadan and at the end of the fasting month. 
Studies in 1993 and 1975 showed slight increases in serum Glucose levels. 
Maislos conducted a study consisting of twenty-four healthy subjects.  Blood 
value testing was performed at day 26 and 27 of Ramadan and at one month after 
Ramadan.  Mean serum blood Glucose concentrations slightly increased from 
79.00mg/dL to 83.00mg/dL, an elevation of 4.82% (Maislos et al, 1993). The 
1975 study included seven males and took a different approach to Glucose testing 
while fasting. They were required to maintain daily dietary records ending one-
week post-Ramadan. Oral Glucose tolerance testing was performed at the 
conclusion of Ramadan and again 12 weeks later.  Documented mean Glucose 
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levels were 85.00mg/dL elevating to 89.00mg/dL or a 4.71% increase in serum 
Glucose levels.  Also noteworthy, were their findings of a correlation between 
“increased ability to dispose of Glucose and enhanced Insulin secretion in 
response to an oral Glucose challenge” (Angel and Schwartz, 1975). 
Slightly higher increases in Glucose levels were reported from a study by 
El Ati et al conducted using sixteen women as subjects.  Four laboratory-testing 
dates were utilized: 2 days before fasting, the 2nd and the 28th days of Ramadan 
and, finally, one month after Ramadan.  An increase in serum blood Glucose 
levels of 7.2% were noted; with mean levels rising from 87.56 to 93.86 (El Ati et 
al, 1995).  
When caloric intake is restricted for extended periods of time a state 
known as fasting occurs.  Whether fasting for medical, personal or religious 
reasons Glucose may not always be readily accessible as a fuel source, the body is 
then forced to manufacture it from other nutrients, such as from fatty acids found 
in adipose tissue or proteins found in muscle tissue. The use of fatty acids for fuel 
usually begins when the post-absorptive phase exceeds 14-16 hours. It is the 
breakdown and utilization of proteins for energy over extended periods, which 
can become a life-threatening occurrence due to the wasting of proteins causing 
organ failure (Spriet et al, 2004; Wardlaw; Kessel, 2002 and Smith, 2005).  
A few studies examined both Glucose and Insulin concentration levels 
during fasting. In 2004, a group of medical physicians examined female 
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participates during Ramadan. They focused on Glucose and Insulin levels while 
fasting. Serum levels were run on the 14th and 28th day of Ramadan; baseline 
was established prior to beginning of fast.  A mean Glucose of 97.47mg/dL 
(baseline) decreased to a mean of 94.94mg/dL on the 28th day, a drop of 2.59%. 
Insulin concentration levels showed a negligible increase from a mean of 
7.3µU/mL (baseline) to a mean of 8.83µU/mL (Kassab et al, 2004). A study of 
eight mid-distance athletes revealed mean Insulin levels of 20.0 U.1ˉ¹ (baseline) 
to 26.1 U. 1ˉ¹ one week after Ramadan (Chennaoui et al, 2009). Other studies 
revealed no substantial changes in Insulin concentration levels (Fedail et al, 1982; 
Bouhlel et al, 2008). 
 As previously stated; as blood sugar levels decrease Insulin production 
and secretion is inhibited; as this occurs the release of Glucagon is stimulated.  
Glucagon is a peptide hormone released by the alpha cells of the pancreas when 
blood Glucose levels fall.  When Glucagon is secreted it acts on the hepatocytes 
to activate the enzymes that are necessary for the breakdown and return of 
glycogen into Glucose.  Knowing that Glucagon’s major function is to increase 
blood Glucose levels, it makes sense that Glucagon is secreted in response to 
hypoglycemia or low blood concentrations of Glucose (Spriet et al, 2004 and 
smith et al, 2005. 
Cortisol is a major glucocorticoid and the third hormone of interest to this 
investigation in relation to fasting the month of Ramadan. It is produced in the 
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adrenal cortex and released in response to fasting and high stress situations. 
Cortisol is a counterregulatory hormone for Insulin.  Like Glucagon cortisol reacts 
to occurrences of hypoglycemia, whether from excess stress, fasting or low blood 
sugars related to high levels of serum Insulin, glycogenolysis. Some of the 
pathways for Glucose synthesis from amino acids (gluconeogenesis) are induced 
by cortisol as well as by Glucagon (Smith et al, 2005).  
Cortisol levels are included in Ramadan studies in order to explore 
alterations in biological rhythm-circadian cycles, as well as the effects of fasting 
on biochemical processes. A study by Maughan et al in 2008 divided 78 male 
athletes into two fasting and two non-fasting groups. Samples were obtained at 3-
week pre-Ramadan (baseline) and after 2-week and 4-week; the results were 93 
µg.1ˉ¹, 108 µg.1ˉ¹, and 111 µg.1ˉ¹, for fasting group, respectively. When 
comparing the baseline with the second week result there was an elevation of 
16.13%, that elevation was increased to 19.35% at week four of Ramadan. For 
non-fasting group the baseline was 149 that value remained a constant for 2 
weeks and increased to 7.38% at the end of Ramadan. 
Another study on cortisol during Ramadan was conducted by Al-Hadramy 
in 1987, participants was 7 men and 3 women. Samples were obtained at 1-day 
pre-Ramadan (baseline) and day 24 of fasting, results was 348 nmol/l and 542 
nmol/l, respectively. Comparing the baseline with day 24 resulted in an elevation 
of 55.75%.  These two studies are in conflict with the results of Chaouachi et al in 
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2007.  Fifteen athletes were examined on cortisol levels during Fasting Ramadan. 
The samples were obtained 4 day pre Ramadan, 7, 16, and day 29 of fasting 
Ramadan, the results were 13.4 mg.1ˉ¹, 9.0 mg.1ˉ¹, 9.3 mg.1ˉ¹, and 10.3 mg.1ˉ¹, 
respectively. When comparing the baseline with day 7, 16, 29, results were 
decreased 32.48%, 30.6%, 32.13%, respectively.    
 The physiological relationship between cortisol and creatinine in the 
human body is understood and acknowledged. In times of stress or extreme 
muscle trauma whether damage is from excessive over-use or traumatic accident 
cortisol a glucocorticoid can be released in response to several different 
biochemical requirements. When muscles are stressed or extensively damaged 
enough to warrant increased muscle metabolism cortisol is able to stimulate 
amino acid mobilization from muscle protein. The waste product of this 
metabolism is creatinine. A muscle like every other structure in the body requires 
fuel. When Glucose levels are low cortisol acting as a counter regulatory hormone 
may be released in the body stimulating gluconeogenesis, thus, providing muscles 
with fuel for muscle protein metabolism which in turn produces creatinine (Smith 
et al, 2005). 
Creatinine is produced as a waste by product generated from muscle 
metabolism. It is produced from creatine, a molecule of major importance for 
energy manufacture in muscles. Approximately 2% of the body’s creatine is 
converted to creatinine daily. Creatinine is transported through the bloodstream 
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and filtered by the kidneys. Creatinine levels are a key indicator of several 
metabolic occurrences’ as well as acute and chronic medical conditions. 
Decreased muscle mass related to eating disorders, inadequate intake of dietary 
protein or malnutrition as well as degenerative muscle diseases can cause 
decreased levels of creatinine. Serum levels can also increase with muscle damage 
such as immediately following Myocardial Infarction or muscle damage from 
extreme over use. Abnormally, elevated concentrations in urine could indicate 
renal dysfunction (Venes, 2005; Fischbach, 1998; Smith, 2005).  
As previously stated elevated creatinine levels can be an indicator of 
muscle damage in the human body. Studies have explored the effects of fasting 
Ramadan on creatinine levels in humans. While both Maislos et al and Ramadan 
et al reported no vital changes in creatinine levels in the their data of fasting 
studies, Ramadan et al did explore a bit further by dividing his group into active 
and sedentary subjects and looked at pre-and post-Ramadan creatinine levels. The 
results of active group presented with mean values of 99.3mg/dl (baseline) with 
an elevation to 104.30mg/dl, a change of 5.04% (Table 8).  While the sedentary 
group data had a mean value of 95.14mg/dl (baseline) to 95.29mg/dl, a change of 
0.16% (Ramadan et al, 1999). 
However, another study documented decreases in creatinine levels. Lab 
values showed a mean of 71mg/dl (baseline) with a decrease to 63mg/dl, a drop of 
11.27 were noted (Beltaifa et al, 2002). Nineteen male subjects were divided into 
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two groups, one tested after feeding and the other tested after fasting. The fasting 
group is the focus of this study. Creatinine values went from a mean of 
87.80mg/dl (baseline) to 94.42mg/dl, a change of 7.52% (Trabelsi et al, 2012). 
Another study that demonstrated marked changes was Bouhlel et al in 2008. They 
evaluated the participants before and after exercise at one week before Ramadan, 
10 days and the last day of Ramadan. Pre-exercise values had a mean of 
71.9mg/dl (baseline) and 78.1mg/dl, an increased change of 8.62%, while post-
exercise values were a mean of 83.1mg/dl (baseline) to 72.1mg/dl, a decreased 
change of 13.24% (Bouhlel et al, 2008).  
In summary, fasting influences many physiological functions. It can 
induce positive as well as potentially harmful metabolic responses within the 
body. Multiple actions as well as biochemical responses come into play when the 
human body detects hypo or hyperglycemic states. The pancreas produces 
increased levels of Insulin in response to hyperglycemic episodes just as Insulin 
levels are decreased for periods of hypoglycemia. The liver also rapidly responds 
to hyper and hypoglycemic occurrences by aiding in the adjustment of Glucagon 
and the storage of glycogen. Gluconeogenesis, the manufacture of Glucose from 
amino acids and fats instead of from carbohydrates, occurs when a person’s 
caloric intake changes such as in the state of fasting. Clearly, fasting has a more 
positive than negative effect on lipid serum levels.  Studies produce visible proof, 
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via blood serum values, that metabolic marker’s such as total cholesterol, high-
density lipids and triglyceride levels can positively be affected by fasting.  
Fasting during Ramadan frequently alters the body’s natural rhythm 
cycles. Our patterns of eating, sleeping, and socialization can all be affected. 
Cortisol levels play a significant role in adjusting and supporting these 
physiological rhythms. Gluconeogenesis and glycogenolysis are affected by 
fasting and can both be stimulated by cortisol release in response to hypoglycemic 
as well as decreased protein levels in the body. 
A positive aspect in research related to fasting during Ramadan is an 
increase in the number of studies exploring and evaluating exercise versus non-
exercise groups along with different types of exercise during the month of 
Ramadan (Ramadan et al, 1999, Bouhlel et al, 2008).  
The collection of data related to creatinine levels, muscle damage and long 
term fasting could provide valuable insight to our scientific communities. Without 
a doubt, data collected through research of the month of Ramadan and fasting 
could be increasingly advantageous to many health aspects, education, and 
exercise professionals. 
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Table 7-1: show the effect of fasting during the month of Ramadan on Glucose   
Baseline Glucose 
(mg/dl)  
Ramadan Glucose 
(mg/dl)  
% Changes  Reference   
84.00 F3,M10 74.00 -11.90* Muazzam and Khaleque (1959) 
85.00M7 89.00 4.71 Angel and Schwartz (1974) 
192.77F10,M12 196.37 1.87 Mafauzy et al. (1990)   
79.00 F8,M16 83.00 4.82 Maislos et al (1993) 
87.56F16 93.86 7.20 El Ati et al. (1995)  
91.88M32 78.91 -14.12* Adlouni et al. (1997) 
84.10F,M26 82.30 -2.14 Nagra et al (1998) 
92.57F,M50 90.22 -2.54 Asgary et al. (2000) 
75.80F27 92.60 22.16* Temizhan et al. (2000)  
77.70M25 91.90 18.28* Temizhan et al. (2000)  
82.15M,F10 79.63 -3.07 Khan and Khattak (2002) 
89.70F48 65.70 -26.76* Larijani et al. (2003)  
87.50M67 60.80 -30.51* Larijani et al. (2003)   
* Significant; Baseline would be the point where the subjects were not fasting the month of 
Ramadan; Ramadan would be the point where the test was performed during the last week of 
Ramadan; AR the test of body weight was taken after Ramadan; BW body weight; M the 
subjects were male; F the subjects were female; F,M  the subjects were female and male;  uW the 
subjects were underweight. oW the subjects were overweight;  nW the subjects were normal; S 
Sedentary; A Activity 
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Table 7-2: show the effect of fasting during the month of Ramadan on Glucose 
Baseline Glucose 
(mg/dl)  
Ramadan Glucose 
(mg/dl)  
% Changes  Reference   
100.53 F,M60 101.07 0.54 Dowod (2004) 
95.30 M20 85.60 -10.18* Rahman et al (2004) 
97.47 F46 94.94 -2.59 Kassab et al. (2004)  
78.20F39 69.70 -10.87* Ziaee Vetal (2006)  
75.00M41 68.80 -8.27* Ziaee Vetal (2006)  
79.60 F,M80 69.20 -13.07* Ziaee Vetal (2006)  
181.70 M9 185.57 2.13 Bouhlel et al (2008) 
109.30 F5,M9 96.40 -11.80* Ibrahim et al (2008) 
189.43 M10 185.57 -2.04 Trabelsi et al (2011) 
189.05 M19 185.95 -1.64 Trabelsi et al (2012) 
* Significant; Baseline would be the point where the subjects were not fasting the month of 
Ramadan; Ramadan would be the point where the test was performed during the last week of 
Ramadan; AR the test of body weight was taken after Ramadan; BW body weight; M the 
subjects were male; F the subjects were female; F,M  the subjects were female and male;  uW the 
subjects were underweight oW the subjects were overweight;  nW the subjects were normal; S 
Sedentary; A Activity   
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Table 8: show the effect of fasting during the month of Ramadan on Creatinine  
Baseline Creatinine  
(µmol/l)  
Ramadan Creatinine  
(µmol/l) 
% Changes  Reference   
73.8 F16 79.1 7.18 El Ati et al (1995) 
71.00 F8,M14 71.00 0.00 Maislos et al (1998)  
99.30 M6 A 104.30 5.04 Ramadan et al (1999) 
95.14 M7 S 95.29 0.16 Ramadan et al (1999) 
71.00 F,M20 63.00 -11.27* Beltaifa et al (2002) 
86.90 M16 88.20 1.50 Ramadan (2002) 
71.90 M9 78.10 8.62 Bouhlel et al (2008) 
83.10 72.10 -13.24 Bouhlel et al (2008) 
87.80 M19 94.40 7.52* Trabelsi et al (2012) 
* Significant; Baseline would be the point where the subjects were not fasting the month of 
Ramadan; Ramadan would be the point where the test was performed during the last week of 
Ramadan; AR the test of body weight was taken after Ramadan; BW body weight; M the 
subjects were male; F the subjects were female; F,M  the subjects were female and male;  uW the 
subjects were underweight oW the subjects were overweight;  nW the subjects were normal; S 
Sedentary; A Activity   
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2.5 The physical performance of Muslim athletes during Ramadan 
The Muslim athletes in the London Olympic Games of 2012 were facing 
an immense challenge as they compete during the fast of Ramadan. There is a 
similarity between fasting and a single bout of endurance exercise on metabolic 
stress. Each type of stress causes a depletion of energy resources within the 
human body (Stannrd, 2011).  
Memari with others in 2011 established that the time-span of an 
individual’s agility performance test was significantly affected by fasting during 
Ramadan. Interestingly, the vertical board jump and the balance performance did 
not show any statistical changes. Conversely, a study by Kordi in 2011, revealed 
no noteworthy changes in any times related to agility performance or vertical 
jumping.  
A study conducted by Meckel with others tested different variables of 
performance such as a: vertical jump, 40m run, 4 x10m shuttle run, sum 6 x 40m 
run,  and a 3000m run. They found that the aerobic endurance was significantly 
decreased based on the increased time of a 3000m run lasting from 812.8 seconds 
to 819.9 seconds at the end of Ramadan fast. In addition, they found the ability of 
jumping was decreased significantly from 44.8 cm to 44.0 cm. In their study, 
which consisted of nineteen healthy young male soccer players, a significant 
decrease in athletic performance capacities was confirmed.  
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Nine subjects in a study that was conducted by Abdedlmalek et al in 2011 
performed Wingate test. Subjects participated in a three-part exercise plan 
consisting of the first and fourth week of Ramadan, followed up with a last 
session at three weeks after Ramadan.  The conclusions of that study noted that 
there was no significant difference during the occasions of testing.  
Chennaoui with others in 2009 conducted a study on eight middle distance 
athletes. Their results showed that the maximal aerobic velocity test was 
influenced negatively by fasting during Ramadan which was statistically 
significant by comparing days 7 and 21 of Ramadan with 5 days prior to start of 
Ramadan. Also, they looked at fatigue, which was significantly increased at the 
end of Ramadan from 5.0 to 7.3.   
A comparison study was conducted of sedentary and active males in response to 
physical exercise training sessions during Ramadan. The subjects were thirteen 
healthy men who were tested using the sub-maximal test on a bicycle ergometer 
for maximal oxygen consumption, ventilation, carbon dioxide output, the 
respiratory exchange ratio and the heart rate. They found the maximal aerobic 
capacity was considerably higher in the active group in comparison to the 
sedentary group and the respiratory exchange ratio was decreased significantly in 
both groups at the end of RF and only for the A group the heart rate was notably 
decreased while there were no prominent differences in the other variables 
(Ramadan et al, 1999). In a subsequent study in 2002 Ramadan confirmed his 
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earlier findings of diminished heart rate and ventilation at the end of Ramadan in 
correlation to performance testing (Ramadan, 2002).  
In summary, the athletes performance were influenced by fasting the 
month of Ramadan on endurance ability. However, the results on the strength and 
power performance were inconsistent in the studies conducted during Ramadan 
fasting. It is important to consider that the length of a sport event is the major 
factor that may influence the performance of athletes during fasting Ramadan.  
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CHAPTER III 
METHODS & PROCEDURES  
3.1 Participants  
Ten healthy athletic male subjects without any known disease or taking 
any medication that influenced lipid profile, Glucose, hormone levels were 
randomly selected from a first division Saudi soccer league (Raka Soccer 
League).  
3.2 Study Design  
Subjects were asked to come to the Prince Faisal Bin Fahad Sports 
Medicine Hospital four times. Table 3.1 shows the timeline of the testing and 
procedures. Two times before the month of Ramadan, while the other two during 
the month of Ramadan. The first visit was one week before the month of 
Ramadan and health history and physical activity were obtained while the second 
visit was at one day before the month of Ramadan. The third visit was on the 10th 
of Ramadan while the fourth visit was on the 28th of Ramadan. During each visit, 
physical activity, height and weight were determined.  During the last three visits 
the body composition was measured using a Dual Energy X-ray Absorptiometry 
(DEXA) measurement, venous blood was collected using standard venipuncture 
technique.  The subjects were asked to recall their diet for the three days prior to 
the second, third and fourth visit.  In addition, the subjects were asked to eat the 
same amount and type of food one day before each visit. 
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Visit 1 Visit 2 Visit 3 Visit 4 
1 week prior to Ramadan 1 day prior to Ramadan 10th day of Ramadan 28th day of Ramadan 
Questionnaires 
Health History 
Physical Activity 
 
 
Physical Activity 
Questionnaire 
3 day diet recall 
DEXA scan 
Fasting blood draw  
Physical Activity 
Questionnaire  
3 day diet recall  
 DEXA scan  
 Fasting blood draw  
Physical Activity 
Questionnaire  
3 day diet recall 
DEXA scan  
Fasting blood draw  
 Table 3-1 timeline of testing procedures    
 
 
 
3.2.1 Anthropometric  
  Each individual had have his height measured and his weight was 
recorded. We used a standard height measurement chart and the obtained 
measurement was rounded to the nearest centimeter (cm). Each subject’s weight 
was obtained utilizing a standard digital weight scale and rounded to the nearest 
0.1 kilogram (kg). Body fat and lean body mass was obtained through the use of 
Dual-Energy X-ray Absorptiometry (DEXA). During this test, subjects were 
asked to lay face up, on a padded table, motionless for 7-15 minutes while the 
scanner arm of the DEXA machine passes over their entire body to examine body 
composition (relative amounts of fat mass and lean body mass). 
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3.2.2 Blood Analysis  
Blood samples were analyzed for lipid profile, Glucose, Insulin, Cortisol, 
Glucagon, Albumin and Total protein venous blood was collected from the 
antecubital fossa using standard venipuncture technique. A sterile 20G, 11/2 inch 
needle attached to a sterile 10ml syringe (Becton Dickinson & Co., Franklin 
Lakes, NJ) with leur-lock adaptor was used for all test subjects at each blood 
draw. Prior to each blood draw, the subject was requested to sit for 30 minutes to 
minimize risk of hemoconcentration of blood sample. All blood sampling was 
performed at 1800 hours on the day of testing; in the fasting state.  
After obtaining the sample, 10 ml of venous blood was transferred to two 
Vacutainer tubes containing no additives (Becton Dickinson Vacutainer Systems, 
Franklin Lakes, NJ). Blood was allowed to clot for 30minutes at 25oC. Blood was 
centrifuged for 15 minutes at 4oC. Serum sample was stored at -80oC and remain 
stable for at least one month. The following day all samples for each subject was 
run in duplication in the same assay. 
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3.2.4  Dietary Recall and Physical Activity  
  All subjects were asked to record food and drink consumption (including 
portion sizes) for three days (two weekdays and one weekend day) prior to their 
2nd, 3rd and 4th visit. The Arab Food Analysis Program was used to analysis the 
food intake. In addition, the subjects filled physical activity questioners for seven 
consecutive days prior 2nd, 3rd and 4th visit. The Global Physical Activity 
Questionnaire (QPAG) Analysis Guide was used to analysis the physical activity.  
 
 
3.2.5 Statistic  
We used SPSS package to analyze the data for all variables (Body Weight, 
Fat Body Mass, Lean Body Mass, Ratio of Andriod to Gynoid, Glucose, Insulin, 
Glucagon, Cortisol, Albumin, Total Protien, TC, TG, LDL, VLDL, Ratio LDL to 
HDL, Physical Activity, Vigorous Activity, Moderate Activity, Walking Activity, 
Energy Intake, Protein Intake, Fat Intake and Carbohydrate Intake). Data was 
expressed as means ± SD and were analyzed using analysis variance repeated 
measures a 1x3 ANOVA. P < 0.05 was accepted as statistically significant.  
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RESULTS  
 
4.1 Description of the subjects  
The subject characteristics are presented as mean and standard deviation 
(M ± SD) in table 4.1. The data was obtained from eight subjects who were 
athletic soccer players from a first division Saudi soccer league (Raka Soccer 
League) with an average age of 21.752.05, average height of  170.685.21cm 
and average body weight of 66.737.51kg. The sample size was too small to 
evaluate whether assumptions of multivariate normality were satisfied. The 
Mauchly test was performed to assess possible violation of the sphericity 
assumption 
4.2 Body composition  
  The data of body weight kg (BW), Lean body mass, Body Fat percentage 
(BF%) and Android to Gynoid Ration (A/G) are presented in Table 4.2 as means 
and standard deviations. To evaluate whether intermittent fasting effect BW, 
Lean, BF% and A/G levels on athletic soccer players, one-way repeated measures 
ANOVA were performed. Eight participants were tested under three measurement 
conditions: baseline one day before Ramadan (D1), after ten days of fasting 
Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). The Mauchly 
test was performed to assess possible violation of the sphericity assumption; this 
was not significant for BW, Lean, BF% and A/G as presented in table 4.3, which 
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suggests that the sample size is too small and therefore this test may not have 
sufficient power to detect violations of sphericity. The Greenhous-Geisser £ value 
of 0.964, 0.903, 0.666, and 0.748 for BW, Lean, BF% and A/G, respectively 
suggested that the sample variance/covariance matrix did not depart substantially 
from sphericity. Because the Greenhouse-Geisser ƹ value was close to 1, no 
correction needs to be made to the degrees of freedom used to evaluate the 
significance of the F ratio.  
The overall F of differences in mean BW and Lean across the three 
measurement conditions was statistically significant: F (2, 14) = 7.200, p=.007 
and F (2, 14) = 8.648, p =.004, respectively; the corresponding effect size was a 
partial 𝜋2 of .507, and .553 for BW and Lean, respectively. In other words, after 
stable individual differences in BW and Lean are taken into account, 
approximately 50%, and 55% of the variances were related to intermittent fasting. 
Note that even if the ƹ correction factor is applied to the degrees of freedom for F, 
the obtained value of F for differences in mean BW and Lean among the three 
times of testing remains statistically significant.  
Planned contrasts were obtained to compare the three times of measuring 
the levels of BW and Lean.  
 BW levels during baseline (M D1 = 66.73) were similar to the mean of 
BW during the D10 (M D10 =66.73). There was no significant difference between 
the two means: t (7) = .000, p =.1.000. However, the mean difference between 
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BW during D10 (M D10 = 66.73) and D28 (M D28 =65.53) was statistically 
significant: t (7) = 3.136, p=.016. In addition, BW during the baseline (M D1 = 
66.73) was also higher than the mean of BW during D28 (M D28 =65.53). The 
mean difference between D1 and D28 was statistically significant: t (7) = 3.140, 
p=.016. A graph of Body Weight means change appears in figure 4.1. Thus, of the 
three measure interventions in this study, only the comparison between the 
baseline with D10 and D28 had significant changes. 
Lean body mass levels during baseline (M D1 = 50.519) were almost 
identical to the mean of Lean body mass during the D10 (M D10 =50.469). There 
were no significant difference between the two means: t (7) = .189, p =.856.  
However, the mean difference between Lean during D10 (M D10 = 50.469) and 
D28 (M D28 =49.462) was statistically significant: t (7) = 3.049, p=.019. In 
addition, Lean during the baseline (M D1 = 50.519) was also higher than the mean 
of Lean during D28 (M D28 =49.462). The mean difference between D1 and D28 
was statistically significant: t (7) = 4.115, p=.004. A graph of Body Weight means 
change appears in figure 4.2. Thus, of the three measure interventions in this 
study, only the comparison between the baseline with D10 and D28 had 
significant changes.   
BF% and A/G showed no significant differences between all the 
measurements. The overall F of differences in mean BF% and A/G across the 
three measurement conditions was also not statistically significant:  F (2, 14) 
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=.033, p =.968 and F (2, 14) = 1.334, p = .295, respectively; the corresponding 
effect size was a partial 𝜋2 of 0.005 and 0.160. In other words, after stable 
individual differences in BF% and A/G are taken into account, 0.5% and 16% of 
the variance in BF% and A/G respectively were related to intermittent fasting. 
Note that even if the ƹ correction factor is applied to the degrees of freedom for F, 
the obtained value of F for differences in mean BF% and A/G among the three 
times of testing remains not statistically significant. A graph of BF% and A/G 
means change appears in figure 4.3 and 4.4. 
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4.3 Glucose, Blood Proteins and Hormones  
The data of Glucose, blood proteins and hormones are presented in table 
4.4 as means and standard deviations. To evaluate whether intermittent fasting 
effect Glucose, Insulin, Glucagon, Cortisol, Albumin and Total Protein levels on 
athletic soccer players, one-way repeated measures ANOVA was performed. The 
Mauchly test was performed to assess possible violation of the sphericity 
assumption; this was not significant for Glucose, Insulin, Glucagon, Cortisol 
Albumin and Total protein as presented in table 4.5. It suggested that the sample 
size is to small; this test may not have sufficient power to detect violations of 
sphericity. The Greenhous-Geisser £ value of 0.628, 0.623, 0.640, 0.943, 0.657, 
0.992 for Glucose, Insulin, Glucagon, cortisol, albumin and total protein, 
respectively suggested that the sample variance/covariance matrix did not depart 
substantially from sphericity. Because the Greenhouse-Geisser ƹ value was 
sufficient, no correction needs to be made to the degrees of freedom used to 
evaluate the significance of the F ratio.  
The overall F of differences in mean Glucose, Glucagon and Albumin 
across the three measurement conditions was statistically significant: F (2, 14) = 
4.025, p=.042; F (2, 14) = 6.16, p =.012; F (2, 14) = 23.47, p=.001 respectively; 
the corresponding effect size was a partial 𝜋2 of .365, .468 and .770 for Glucose 
Glucagon and Albumin, respectively. In other words, after stable individual 
differences in Glucose, Glucagon and Albumin are taken into account, about 36%, 
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46% and 77% of the variance in Glucose, Glucagon and Albumin, respectively 
were related to intermittent fasting. Note that even if the ƹ correction factor is 
applied to the degrees of freedom for F, the obtained value of F for differences in 
mean Glucose, Glucagon and Albumin among the three times of testing remains 
statistically significant.  
Planned contrasts were obtained to compare between the three times of 
measuring the levels of Glucose, Glucagon and Albumin.  
 Glucose levels during baseline (M D1 = 81.87) were found lower than the 
mean of Glucose during the D10 (M D10 =90.75). The difference between the two 
means was not statistically significant: t (7) = -2.095, p =.074. In addition, the 
mean difference between Glucose during D10 (M D10 = 90.75) and D28 (M D28 
=91.00) was not statistically significant: t (7) = -0.057, p=.956. However, Glucose 
during the baseline (M D1 = 81.87) was lower than the mean of Glucose during 
D28 (M D28 =91.00).  The mean difference between D1 and D28 was statistically 
significant: t (7) = -5.164, p=.001. A graph of Glucose means change appears in 
figure 4.5. Thus, of the three measure interventions in this study, only the 
comparison between D1 and D28 had significant changes.  
 Glucagon levels during baseline (M D1 = 42.87) were found greater than 
the mean of Glucagon during the D10 (M D10 =29.12). The difference between the 
two means was statistically significant: t (7) =3.346, p =.012. In addition, the 
Glucagon Levels during the baseline (M D1 = 42.87) were also greater than the 
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Glucagon mean during D28 (M D28 =34.00). However, the mean difference 
between Glucagon D1 and D28 was not statistically significant: t (7) = 1.761, 
p=.122. Also, the mean difference between Glucagon during D10 (M D10 = 29.12) 
and D28 (M D28 =34.00) was not statistically significant: t (7) = -2.177, p=.066. A 
graph of Glucagon means change appears in figure 4.6. Thus, of the three times 
interventions in this study, only D10 had significantly lower mean Glucagon than 
D1 baseline. 
Albumin levels during baseline (M D1 = 46.75) were found greater than the 
mean of Albumin levels during the D10 (M D10 =42.50). The difference between 
the two means was statistically significant: t (7) =5.19, p =.001. In addition, 
Albumin during the baseline (M D1 = 46.75) was also greater than the mean of 
Albumin during D28 (M D28 =41.25). The mean difference between Albumin D1 
and Albumin D28 was statistically significant as well: t (7) = 10.29, p=.001. 
However, the mean difference between Albumin during D10 (M D10 = 42.50) and 
Albumin D28 (M D28 =41.25) was not statistically significant: t (7) = 1.15, 
p=.29. A graph of Albumin means change appears in figure 4.7. Thus, of the three 
measure interventions in this study, only D10 and D28 had significantly lower 
mean than baseline.  
Insulin, Cortisol and Total Protein showed no significant differences 
between all the measurements. The overall F of differences in mean Insulin, 
Cortisol and Total Protein across the three measurement conditions was not 
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statistically significant:  F (2, 14) =.539, p =.595; F (2, 14) = 1.637, p =.230 and F 
(2, 14) = 1.135, p = .349, respectively; the corresponding effect size was a partial 
𝜋2 of 0.071, 0.19, and 0.14. In other words, after stable individual differences in 
Insulin are taken into account, about 7%, 19% and 14% of the variance in Insulin, 
Cortisol and Total Protein respectively were related to intermittent fasting. Note 
that even if the ƹ correction factor is applied to the degrees of freedom for F, the 
obtained value of F for differences in mean Insulin, Cortisol and Total Protein 
among the three times of testing remains not statistically significant. A graph of 
Insulin, Cortisol and Total Protein means change appears in figure 4.8, 4.9 and 
4.10, respectively. 
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4.4 Lipid Profiles  
The data of total cholesterol (TC), triglycerides (TG), low-density 
lipoprotein (LDL), high-density lipoprotein (HDL), very low-density lipoprotein 
(VLDL) and the ratio of low-density lipoprotein to high-density lipoprotein 
(LDL/HDL) are presented in Table 4.6 as means and standard deviations. To 
evaluate whether Ramadan fasting effect TC, TG, LDL, HDL, VLDL and 
LDL/HDL levels on athletic soccer players, a one-way repeated measures 
ANOVA was performed. The Mauchly test was performed to assess possible 
violation of the sphericity assumption; this was not significant for TC, TG, LDL, 
HDL, VLDL and LDL/HDL as presented in table 4.7. It suggested that the sample 
size is too small; this test may not have sufficient power to detect violations of 
sphericity. The Greenhous-Geisser £ value of 0.593, 0.631, 0.575, 0.858, 0.631, 
0.894 for TC, TG, LDL, HDL, VLDL and LDL/HDL, respectively suggested that 
the sample variance/covariance matrix did not depart substantially from 
sphericity. Because the Greenhouse-Geisser ƹ value was sufficient, no correction 
needs to be made to the degrees of freedom used to evaluate the significance of 
the F ratio.  
The overall F of differences in mean LDL/HDL across the three 
measurement conditions were statistically significant: F (2, 14) = 11.301, p=.001; 
the corresponding effect size was a partial 𝜋2 of .618. In other words, after stable 
individual differences in LDL/HDL are taken into account, about 62% of the 
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variance in LDL/HDL was related to fasting Ramadan. Note that even if the ƹ 
correction factor is applied to the degrees of freedom for F, the obtained value of 
F for differences in mean LDL/HDL among the three times of testing remains 
statistically significant.  
Planned contrasts was obtained to compare between the three times of 
measuring the levels of LDL/HDL.  
 LDL/HDL levels during baseline (M D1 = 1.76) were found lower than the 
mean of LDL/HDL during the D10 (M D10 =2.01). The difference between the two 
means was statistically significant: t (7) = -2.975, p =.021. Also, LDL/HDL 
during the baseline (M D1 = 1.76) was lower than the mean of LDL/HDL during 
D28 (M D28 =91.00). The mean difference between D1 and D28 was statistically 
significant: t (7) = -4.136, p=.004. However, the mean difference between 
LDL/HDL during D10 (M D10 = 2.01) and D28 (M D28 =2.22) was not statistically 
significant: t (7) = -2.266, p=.058. A graph of LDL/HDL means change appears in 
figure 4.11. Thus, of the three measure interventions in this study, only the 
comparison between D1 with D10 and D28 had significant changes.  
TC, TG, LDL, HDL and VLDL showed no significant differences 
between all the measurements. The overall F of differences in mean TC, TG, 
LDL, HDL and VLDL across the three measurement conditions was not 
statistically significant: F (2, 14) = .297, p = .748; F (2, 14) = 1.803, p =.201; F (2, 
14) = 2.391, p = .128; F (2, 14) = 2.88, p =.089; and F (2, 14) = 1.803, p =.201, 
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respectively; the corresponding effect size was a partial 𝜋2 of 0.041, 0.205, 0.255, 
0.292, and 0.205, respectively. In other words, after stable individual differences 
in TC, TG, LDL, HDL and VLDL are taken into account, about 4%, 20%, 25%, 
29% and 20% of the variance in TC, TG, LDL, HDL and VLDL respectively 
were related to intermittent fasting. Note that even if the ƹ correction factor is 
applied to the degrees of freedom for F, the obtained value of F for differences in 
mean TC, TG, LDL, HDL and VLDL among the three times of testing remains 
not statistically significant.   Graphs of TC, TG, LDL, HDL and VLDL means 
change appears in figure 4.12, 4.13, 4.14, 4.15 and 4.16, respectively. 
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4.5 Physical activities 
  The data of physical activates MET-minutes/week (PA), vigorous (V), 
moderate (M) and walking (W) are presented in Table 4.8 as means and standard 
deviations. To evaluate whether intermittent fasting effect PA, V, M, and W 
levels on athletic soccer players, one-way repeated measures ANOVA were 
performed. Eight participants were tested under three measurement conditions: 
baseline one day before Ramadan (D1), after ten days of fasting Ramadan (D10) 
and twenty-eight days of fasting Ramadan (D28). The Mauchly test was 
performed to assess possible violation of the sphericity assumption; this was not 
significant for PA, V, M and W as presented in table 4.9, which suggests that the 
sample size is too small and therefore this test may not have sufficient power to 
detect violations of sphericity. The Greenhous-Geisser £ value of 0.704, 0.900, 
0.802, and 0.598 for PA, V, M and W, respectively suggested that the sample 
variance/covariance matrix did not depart substantially from sphericity. Because 
the Greenhouse-Geisser ƹ value was sufficient, no correction needs to be made to 
the degrees of freedom used to evaluate the significance of the F ratio.  
The overall F of differences in mean PA, V and M and W across the three 
measurement conditions was statistically significant: F (2, 14) = 29.363, p=.001, 
F (2, 14) = 23.355, p =.001 and F (2, 14) = 8.888, p =.003, respectively; the 
corresponding effect size was a partial 𝜋2 of .807, .769 and .559 for PA, V and M, 
respectively. In other words, after stable individual differences in PA, V and M 
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are taken into account, approximately 80%, 76% and 55% of the variances were 
related to intermittent fasting. Note that even if the ƹ correction factor is applied 
to the degrees of freedom for F, the obtained value of F for differences in mean 
PA, V and M among the three times of testing remains statistically significant.  
Planned contrasts were obtained to compare the three times of measuring 
the levels Physical Activities, Vigorous activities and Moderate activities.   
physical activity levels during baseline (M D1 = 4036) were higher than the 
mean of PA during the D10 (M D10 =3715). There was no significant difference 
between the two means: t (7) = 2.257, p =.059. However, the mean difference 
between PA during D10 (M D10 = 3715) and D28 (M D28 =2309) was statistically 
significant: t (7) = 5.028, p=.002. In addition, PA during the baseline (M D1 = 
4036) was also higher than the mean of PA during D28 (M D28 =2309). The mean 
difference between D1 and D28 was statistically significant: t (7) = 6.351, p=.001. 
A graph of PA  means change appears in figure 4.17. Thus, of the three measure 
interventions in this study, only the comparison between the baseline and D10 
with D28 had significant changes. 
Vigorous physical activity levels during baseline (M D1 = 1500) were 
higher than the mean of V during the D10 (M D10 =1075). There were no 
significant difference between the two means: t (7) = 1.831, p =.110.  However, 
the mean difference between V during D10 (M D10 = 1075) and D28 (M D28 = 45) 
was statistically significant: t (7) = 5.749, p=.001. In addition, PA during the 
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baseline (M D1 = 1500) was also higher than the mean of PA during D28 (M D28 
=45). The mean difference between D1 and D28 was statistically significant: t (7) 
= 6.051, p=.001. A graph of Vigorous physical activity means change appears in 
figure 4.18. Thus, of the three measure interventions in this study, only the 
comparison between the baseline and D10 with D28 had significant changes.   
Moderate physical activity levels during baseline (M D1 = 1305) was lower 
than the mean of M during the D10 (M D10 =1485). There were no significant 
difference between the two means: t (7) = -.606, p =.564.  However, the mean 
difference between M during D10 (M D10 = 1485) and D28 (M D28 = 517) was 
statistically significant: t (7) = 4.244, p=.004. In addition, M during the baseline 
(M D1 = 1305) was also higher than the mean of M during D28 (M D28 =517). The 
mean difference between D1 and D28 was statistically significant: t (7) = 4.009, 
p=.005. A graph of Moderate physical activity means change appears in figure 
4.19. Thus, of the three measure interventions in this study, only the comparison 
between the baseline and D10 with D28 had significant changes.  
Walking activities showed no significant differences between all the 
measurements. The overall F of differences in mean W across the three 
measurement conditions was also not statistically significant:  F (2, 14) = 3.238, p 
=.070; the corresponding effect size was a partial 𝜋2 of .316. In other words, after 
stable individual differences in W are taken into account, 31% of the variance in 
walking was related to intermittent fasting. Note that even if the ƹ correction 
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factor is applied to the degrees of freedom for F, the obtained value of F for 
differences in mean Walking among the three times of testing remains not 
statistically significant. A graph of Walking and means change appears in figure 
4.20. 
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4.6 Food Intakes 
  The data of Energy Intake (EI), Percentage of Calories from Protein 
(CP%), Percentage of Calories from Fat (CF%) and Percentage of Calories from 
Carbohydrate (CC%) are presented in Table 4.8 as means and standard deviations. 
To evaluate whether intermittent fasting effect EI, CP%, CF%, and CC% levels 
on athletic soccer players, one-way repeated measures ANOVA were performed. 
The Mauchly test was performed to assess possible violation of the sphericity 
assumption; this was not significant for EI,  CP%,  CF%, and  CC% as presented 
in table 4.9, which suggests that the sample size is too small and therefore this test 
may not have sufficient power to detect violations of sphericity. The Greenhous-
Geisser £ value of 0.798, 0.969, 0.777, and 0.651for EI,  CP%,  CF%, and  CC%, 
respectively suggested that the sample variance/covariance matrix did not depart 
substantially from sphericity. Because the Greenhouse-Geisser ƹ value was 
sufficient, no correction needs to be made to the degrees of freedom used to 
evaluate the significance of the F ratio.  
The overall F of differences in mean  CP%, and  CC% across the three 
measurement conditions was statistically significant: F (2, 14) = 10.475, p=.002 
and F (2, 14) = 7.321, p =.007, respectively; the corresponding effect size was a 
partial 𝜋2 of .599 and .511 for  CP%, and  CC%, respectively. In other words, 
after stable individual differences in  CP%, and  CC% are taken into account, 
approximately 59% and 51% of the variances were related to the month of 
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Ramadan. Note that even if the ƹ correction factor is applied to the degrees of 
freedom for F, the obtained value of F for differences in mean CP%, and  CC% 
among the three times of testing remains statistically significant.  
Planned contrasts were obtained to compare the three times of measuring 
the levels Percentage of Calories from Protein and Percentage of Calories from 
Carbohydrate intake.   
Percentage of Calories from Protein during baseline (M D1 = 17.57) were 
higher than the mean of  CP% during the D10 (M D10 =12.50). There was 
significant difference between the two means: t (7) = 3.754, p =.007. In addition,  
CP% during the baseline (M D1 = 17.57) was also higher than the mean of  CP% 
during D28 (M D28 =11.35). The mean difference between D1 and D28 was 
statistically significant: t (7) = 3.971, p=.005. However, the mean difference 
between  CP% during D10 (M D10 = 12.50) and D28 (M D28 =11.35) was 
statistically not significant: t (7) = .817, p=.441. A graph of  CP% means change 
appears in figure 4.17. Thus, of the three measure interventions in this study, only 
the comparison between the baseline with D10 and D28 had significant changes. 
Percentage of Calories from Carbohydrate ( CC%) during baseline (M D1 
= 47.79) were lower than the mean of  CC% during the D10 (M D10 =59.01). 
There was significant difference between the two means: t (7) = -2.663, p =.032. 
In addition,  CP% during the baseline (M D1 = 47.79) was also lower than the 
mean of CC% during D28 (M D28 =57.89). The mean difference between D1 and 
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D28 was statistically significant: t (7) = -3.431, p=.011. However, the mean 
difference between  CC% during D10 (M D10 = 59.01) and D28 (M D28 =57.89) 
was statistically not significant: t (7) = .504, p=.629. A graph of  CP% means 
change appears in figure 4.17. Thus, of the three measure interventions in this 
study, only the comparison between the baseline with D10 and D28 had 
significant changes. 
Energy Intake (EI) and Percentage of Calories from Fat ( CF%) showed no 
significant differences between all the measurements. The overall F of differences 
in mean EI and CF% across the three measurement conditions was not statistically 
significant:  F (2, 14) = 2.069, p =.163 and F (2, 14) = 4.323, p =.035 the 
corresponding effect size was a partial 𝜋2 of .228 and .382. In other words, after 
stable individual differences in EI and  CF% are taken into account, 22% and 38% 
of the variance in EI and  CF% respectively was related to the month of Ramadan. 
Note that even if the ƹ correction factor is applied to the degrees of freedom for F, 
the obtained value of F for differences in mean EI and CF% among the three 
times of testing remains not statistically significant. A graph of EI and  CF% 
means change appears in figure 4.20. 
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Table 4.1.Subject characteristics. 
Characteristics  Minimum Maximum Mean  SD 
Age (yrs) 19.00 24.00 21.75  2.05 
Height (cm) 161.50 177.00 170.68  5.21 
Body Weight (kg) 54.70 76.90 66.73  7.51 
Subjects participated in the study (n=8). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
68 
 
 
 
Table 4.2.Changes in Body Composition  
Measurements Before 
Ramadan 
10th of   
Ramadan  
28th of 
Ramadan  
Body Weight(kg) 66.737.51 66.738.05 65.537.63*＾ 
Lean (kg) 50.515.33 50.465.79 49.465.18*＾ 
Fat % 17.882.75 17.812.46 17.863.00 
A/G Ratio 1.210.13 1.190.17 1.150.15 
Data presented as mean  standard deviation. *=significantly different vs. 
baseline (p<0.05). ＾=significantly different vs. D10. 
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Table 4.3. Present data of Mauchly’s Test of Sphericity  
Within 
subjects 
effect 
Mauchly’s 
W 
Approx. 
Chi-Square 
df Sig Greenhouse-
Geisser 
BW .962 .230 2 .892 .964 
Lean .893 681 2 .711 .903 
Fat % .499 4.173 2 .124 .666 
A/G .662 2.473 2 .290 .748 
Test of with-Subjects Effects  
Source df(..,..) F Sig Partial Eta 
Squared 
% 
BW (2,14) 7.200 .007 .507 50 
Lean (2,14) 8.648 .004 .553 55 
Fat % (2,14) .033 .968 .005 0.5 
A/G (2,14) 1.334 .295 .160 16 
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Table 4.4.Changes in Blood variables  
Measurements Before 
Ramadan 
10th of 
Ramadan  
28th of 
Ramadan  
Glucose 81.8704.01 90.7511.90 91.0003.25* 
Insulin 07.6002.63 06.4503.90 06.1803.73 
Glucagon 42.8716.69＾ 29.1208.80 34.0009.97 
Cortisol 13.5705.67 12.5305.71 09.2705.43 
Albumin 46.7501.58＾ 42.5001.85 41.2502.54* 
Total Protein  77.0003.11 74.8705.48 74.6204.37 
Data presented as mean  standard deviation. *=significantly different vs. 
baseline (p<0.05).＾=significantly different vs. D10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
71 
 
 
 
Table 4.5. Present data of Mauchly’s Test of Sphericity  
Within 
subjects 
effect 
Mauchly’s 
W 
Approx. 
Chi-Square 
df Sig Greenhouse-
Geisser 
Glucose .408 5.376 2 .068 .628 
Insulin .394 5.584 2 .061 .623 
Glucagon .438 4.959 2 .084 .640 
Cortisol .939 .376 2 .828 .943 
Albumin .478 4.430 2 .109 .657 
Total Protein .992 .049 2 .976 992 
Test of with-Subjects Effects  
Source df(..,..) F Sig Partial Eta 
Squared 
% 
Glucose (2,14) 4.025 .042 .365 36 
Insulin (2,14) .539 .595 .071 7 
Glucagon (2,14) 6.164 .012 .468 46 
Cortisol (2,14) 1.637 .230 .190 19 
Albumin (2,14) 23.47 001 .770 77 
Total Protein (2,14) 1.135 .349 .140 14 
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Table 4.6.Changes in Lipid profiles 
Measurements Before 
Ramadan 
10th of 
Ramadan  
28th of 
Ramadan  
TC  158.0226.89 158.9817.58 162.8524.31 
TG 96.2060.59 65.2014.70 73.5121.64 
LDL 88.6226.21 96.9315.82 102.0119.92 
HDL 50.2505.06 48.806.51 46.3905.46 
VLDL 19.2412.11 13.0402.94 14.7004.32 
LDL/HDL ratio 01.7600.52＾ 02.0100.41 02.2200.50* 
Data presented as mean  standard deviation. *=significantly different vs. 
baseline (p<0.05). ＾=significantly different vs. D10. 
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Table 4.7. Present data of Mauchly’s Test of Sphericity  
Within 
subjects 
effect 
Mauchly’s 
W 
Approx. 
Chi-Square 
df Sig Greenhous
e-Geisser 
TC .314 6.945 2 .031 .593 
TG .415 5.276 2 .072 .631 
LDL .261 8.070 2 .018 .575 
HDL .834 1.090 2 .580 .858 
VLDL .415 5.276 2 .072 631 
LDL/HDL .882 .757 2 .685 .894 
Test of with-Subjects Effects  
Source df(..,..) F Sig Partial Eta 
Squared 
% 
TC (2,14) .297 .748 .041 4 
TG (2,14) 1.803 .201 .205 20 
LDL (2,14) 2.391 .128 .255 25 
HDL (2,14) 2.882 .089 .292 29 
VLDL (2,14) 1.803 .201 .205 20 
LDL/HDL (2,14) 11.301 .001 .618 61 
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Table 4.8.Changes in Physical Activity Levels   
Measurements Before 
Ramadan 
10th of   
Ramadan  
28th of 
Ramadan  
Physical Activity  4036830 3715829 23091101*＾ 
Vigorous 1500584 1075465 45127*＾ 
Moderate 1305509 1485492 517321*＾ 
Walking 1231985 1155738 17461066 
Data presented as mean  standard deviation. *=significantly different vs. 
baseline (p<0.05). ＾=significantly different vs. D10. 
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Table 4.9. Present data of Mauchly’s Test of Sphericity  
Within 
subjects 
effect 
Mauchly’s 
W 
Approx. 
Chi-Square 
df Sig Greenhouse-
Geisser 
PA .579 3.275 2 .194 .704 
V .889 .709 2 .702 .900 
M .753 1.704 2 .427 .802 
W .327 6.707 2 .035 .598 
Test of with-Subjects Effects  
Source df(..,..) F Sig Partial Eta 
Squared 
% 
PA (2,14) 29.363 .000 .807 80. 
V (2,14) 23.355 .000 .769 76 
M (2,14) 8.888 .003 .559 55 
W (2,14) 3.238 .070 .316 31 
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Table 4.10.Changes in Food Intake  
Measurements Before 
Ramadan 
10th of   
Ramadan  
28th of Ramadan  
Energy 
Intake(Kcal) 
3121489 3080419 2986479 
Protein (%) 17.575.33 12.505.79 11.355.18*＾ 
Fat (%) 38.655.96 29.237.35 31.773.86 
Carbohydrate (%) 47.799.36 59.016.22 57.894.36 
Data presented as mean  standard deviation. *=significantly different vs. 
baseline (p<0.05). ＾=significantly different vs. D10. 
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Table 4.11. Present data of Mauchly’s Test of Sphericity  
Within 
subjects 
effect 
Mauchly’s 
W 
Approx. 
Chi-Square 
df Sig Greenhouse-
Geisser 
Energy Intake 
(Kcal) 
.747 .1.754 2 .416 .798 
Protein (%) .967 .198 2 .906 .969 
Fat (%) .712 2.034 2 .362 .777 
Carbohydrate 
(%)  
.465 4.599 2 .100 .651 
Test of with-Subjects Effects  
Source df(..,..) F Sig Partial 
Eta 
Squared 
% 
Energy Intake 
(Kcal) 
(2,14) 2.069 .163 .228 22 
Protein (%) (2,14) 10.475 .002 .599 59 
Fat (%) (2,14) 4.323 .035 .382 38 
Carbohydrate 
(%)  
(2,14) 7.321 .007 .511 51 
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Figure 4.1. Results of Body weight data for baseline (D1), ten days of fasting 
Ramadan (D10) and twenty-eight days of fasting Ramadan (D28) 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.2. Results of lean (kg) data for baseline (D1), ten days of fasting 
Ramadan (D10) and twenty-eight days of fasting Ramadan (D28) *=significantly 
different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.3. Results Body Fat Percentage data for data for baseline (D1), ten days 
of fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28) 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.4. Results of Android to Gynoid Ratio data for data for baseline (D1), ten 
days of fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28) 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.5. Results Glucose data for data for baseline (D1), ten days of fasting 
Ramadan (D10) and twenty-eight days of fasting Ramadan (D28) 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.6. Results of Glucagon data for baseline (D1), ten days of fasting 
Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). *=significantly 
different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.7. Results of Albumin data for baseline (D1), ten days of fasting 
Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). *=significantly 
different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.8. Results of Insulin data for baseline (D1), ten days of fasting Ramadan 
(D10) and twenty-eight days of fasting Ramadan (D28). *=significantly different 
vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.9. Results of Cortisol data for baseline (D1), ten days of fasting Ramadan 
(D10) and twenty-eight days of fasting Ramadan (D28). *=significantly different 
vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.10. Results of Total Protein data for baseline (D1), ten days of fasting 
Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). *=significantly 
different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.11. Results of LDL/HDL Ratio data for baseline (D1), ten days of fasting 
Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). *=significantly 
different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.12. Results of Total Cholesterol data for baseline (D1), ten days of 
fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.13. Results of Triglycerides data for baseline (D1), ten days of fasting 
Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). *=significantly 
different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.14. Results of Low Density Lipoprotein data for data for baseline (D1), 
ten days of fasting Ramadan (D10) and twenty-eight days of fasting Ramadan 
(D28) *=significantly different vs. baseline (p<0.05). ＾=significantly different 
vs. D10. 
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Figure 4.15. Results of High Density Lipoprotein data for baseline (D1), ten days 
of fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.16. Results of High Density Lipoprotein data for baseline (D1), ten days 
of fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.17. Results of Physical Activity data for baseline (D1), ten days of 
fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
0
500
1000
1500
2000
2500
3000
3500
4000
4500
5000
D1 D10 D28
T
o
ta
l 
P
h
y
sc
ia
l 
A
ct
iv
it
y
 
M
E
T
-m
in
u
te
s/
w
ee
k
 
Physical Activity Changes 
＾*
95 
 
Figure 4.18. Results of Vigorous Physical Activity data for baseline (D1), ten 
days of fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.19. Results of Moderate Physical Activity data for baseline (D1), ten 
days of fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.20. Results of Walking Physical Activity data for baseline (D1), ten days 
of fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.21. Results of Energy Intake Kcal data for baseline (D1), ten days of 
fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.22. Results of Percentage of Calories from Protein data for baseline 
(D1), ten days of fasting Ramadan (D10) and twenty-eight days of fasting 
Ramadan (D28). *=significantly different vs. baseline (p<0.05). ＾=significantly 
different vs. D10. 
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Figure 4.23. Results of Percentage of Calories from Fat data for baseline (D1), ten 
days of fasting Ramadan (D10) and twenty-eight days of fasting Ramadan (D28). 
*=significantly different vs. baseline (p<0.05). ＾=significantly different vs. D10. 
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Figure 4.23. Results of Percentage of Calories from Carbohydrate data for 
baseline (D1), ten days of fasting Ramadan (D10) and twenty-eight days of 
fasting Ramadan (D28). *=significantly different vs. baseline (p<0.05). ＾
=significantly different vs. D10. 
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DISSCUTION  
 
The goal of this investigation was to examine the effects of fasting 
during the month of Ramadan on anthropometrics, Lipid Profile, serum 
protein, Glucose, hormones, physical activity, and food intake. Studies related 
to body weight and food intake during Ramadan, although well documented, 
are inconsistent and contain vastly differing results. In order to maintain 
positive energy balance, energy consumed must be greater than energy 
expended, thus increasing stored energy. Negative energy balance occurs when 
energy expenditure is greater than energy consumed resulting in an energy 
decrease and loss of body weight (Wardlaw and Kessel, 2002). A study done 
by Forst and Pirani (1987) showed that when caloric intake increased, body 
weight also increased during the month of Ramadan. However, Khan and 
Khattak (2002) found a decrease in caloric intake with a decrease in body 
weight. Decreases in caloric intake with reductions in body weight are 
frequently noted in studies (Angel and Schwartz, 1974). A study by El Ati et al 
(1995) found no significant differences related to food intake pre- and post-
Ramadan and body weight.  Other studies documented no notable variations in 
body weight and fat mass correlations (Maislos et al 1993, Beltaifa et al 2002 
and El Ati et al, 1995). Studies that investigate interrelated components of 
weight loss, caloric intake and levels of physical activity during Ramadan are 
less documented.  
103 
 
The findings of this investigation showed a significant decrease of -
1.82 % in body weight at the end of Ramadan. Reflectively, this weight loss 
could conceivably be due to the significant decrease of -6.22 % and -40.57 in 
percentage of calories from protein and the physical activity, respectively. Is 
weight loss in fat body mass or in lean body mass? This study verified that 
weight loss occurred in lean body mass of -2.08 % at the end of Ramadan 
fasting. The loss of lean body mass may have negative impact on the athletic 
performance (Fogelholm, 1994). During the first ten days of Ramadan there 
were no significant changes in body weight which could be due to the non-
significant changes of energy intake and physical activity during the first ten 
days compared to pre Ramadan. Physical activity levels, Vigorous and 
Moderate at the end of Ramadan were considerably diminished. 
Valdimarsson with others conducted a study in 1999 that showed a significant 
positive relationship between lean mass and the physical activity. 
Interestingly, the reduction in lean body mass may correlated to the 
significant reduction of physical activity and insufficient dietary protein 
intake from 10th of Ramadan until the end of Ramadan. It has been confirmed 
that increasing protein intake reduced loss of lean body mass (Mettler et al, 
2010). Moreover, the calories intake from fat was decreased -6.88 % at the 
end of Ramadan compare to pre-Ramadan. However, the reduction of calories 
from fat was not significant.  
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Blood parameters were also investigated in this study. Albumin which 
produced by the liver was significantly decreased to -11.76 % at the end of 
Ramadan. Albumin may be a marker of malnutrition status such as protein 
intake and dehydration. However, Most metabolic and physiological 
functions in the human body derive its’ energy from Glucose. Reliable data 
on the exploration of the effects of fasting on Glucose levels are becoming 
increasingly documented (Asgary et al, 2000 and Nagra et al, 1998). In this 
study, the researcher also examined Fasting Glucose levels were considerably 
elevated at the end of Ramadan when compared to pre-Ramadan to 11.15 %. 
The results of this study are in conflict with previous studies which noted no 
changes in Glucose levels (Fedail et al, 1982 and Bouhelel et al, 2008). One 
study in concurrence with our findings related to elevated Glucose levels was 
Temizhan et al in 2000. Reflectively, the significant increase of Glucose level 
could possibly be due to the significant increase of carbohydrate to 10. % at 
the end of Ramadan. Other blood constituents such as Glucagon have also 
been investigated in this study. Glucagon decreased significantly after the 
first ten days of Ramadan. However, at the end of Ramadan, it returned back 
almost to pre Ramadan levels. The reason why Glucagon levels returned to 
baseline is unclear. The other blood parameters such as Insulin, Cortisol and 
total protein did not show any significant differences throughout the three 
measurements.   
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The changes in eating habits during Ramadan have been well 
documented. One main findings in this study that relate to lipid profiles was 
the significant increase of the LDL/HDL ratio, but was still within normal and 
healthy range.  All other lipid profile values were without significant change. 
Interpretation of data varies somewhat per study. However, smaller meals 
combined with the specific types of caloric intake such as increased 
carbohydrate and decreased fat intake may have a more direct and beneficial 
outcome in controlling lipid levels than one or two large meals during the 
Ramadan fast. Having multiple small meals instead of one or two large meals 
should also be considered a viable contributing factor in lowering total 
cholesterol levels (Lamri-Senhadji et al 2009,  Barkia et al 2011, Aldouni et 
al 1997,  Asgary et al 2000, Bouhlel et al, 2008). 
The physical activity levels were significantly decreased at the end of 
Ramadan because the subjects did not maintain their usual training. During 
the last ten days of Ramadan nightly, the subjects have a tendency to stay up 
until later for praying. The vigorous and moderate physical activity levels 
were significantly reduced at the end of Ramadan. As regards the intensity of 
physical activity, the findings of the present study were consistent with the 
result of Meckel et al 2007. A study conducted by Karli with others 
confirmed that if the daily habits of training, food intake, body fluid balance 
and sleeping were similar in pre and post Ramadan, there would be no effect 
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of Ramadan fasting on body composition and athletic performance. 
 
Summary  
The conflict of our results with the previous studies may be due to the 
possibility of subjects consuming varying amounts of calories between pre-
and post-Ramadan measurements. The inconsistencies of previous studies 
appears to have a direct correlation to the fact that the majority of the studies 
do not control the amount of food intake; nor do they control the level of 
physical activity between these two measurements. Moreover, more research 
needs to be conducted to investigate further the fast of Ramadan in 
relationship not only to body weight, but also to the level of physical activity 
along with the amount and type of food intake. In this study shows that the 
reduction in body weight is related to the loss of lean body mass. Therefore, 
examining the effects of intermittent fasting on human muscle intracellular 
signaling pathways is the future of research in fasting Ramadan. Finally, the 
need for improved control over specific biochemical markers is required. 
Heart disease and diabetes are spreading throughout the world. If altering and 
or varying dietary patterns as studies are beginning to suggest can control, 
elevate and lower these markers without major dietary and pharmacological 
changes, the medical community will gain vital knowledge (Fischbach et al, 
1998 and Venes et al, 2005).  
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ASSUMPTIONS AND LIMITATIONS  
 
The information collected in this study may show people who fast during the 
month of Ramadan that no change will occur when the demand in energy 
intake reaches the demand required by the body in consideration of the 
recommendation dietary allowances per day. In addition, they can fast for an 
extended period of time without harmful physiological or metabolic. 
Likewise, study shows that exercising regularly after breaking the fast with 
complete attention to the time of eating and sleeping has impact on lean body 
mass. Ostensible limitation of this study was the size of the sample. The 
sample was small in size because people think that donating blood while 
fasting is not recommended in Islam unless it is absolutely necessary. 
Donating blood while fasting for research purposes seemed unnecessary to 
the subjects. Another limitation was that the measurement times. Instated of 
having only three times of measuring the subjects it would be better they 
come for testing every three or four days to know at which time the changes 
occur.  
Suggestions for further research  
An area for further research is to conduct a study to scan the effect of 
intermittent fasting on human muscle intracellular signaling pathways. A 
question for further research is “which part of the lean body mass changes? A 
carefule study needs to be conducted in order to answer that question. 
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INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE (August 2002) 
 
 
SHORT LAST 7 DAYS SELF-ADMINISTERED FORMAT 
 
 
 
FOR USE WITH YOUNG AND MIDDLE-AGED ADULTS (15-69 years) 
 
The International Physical Activity Questionnaires (IPAQ) comprises a set of 4 questionnaires. 
Long (5 activity domains asked independently) and short (4 generic items) versions for use by 
either telephone or self-administered methods are available. The purpose of the questionnaires is 
to provide common instruments that can be used to obtain internationally comparable data on 
health–related physical activity. 
 
Background on IPAQ 
The development of an international measure for physical activity commenced in Geneva in 
1998 and was followed by extensive reliability and validity testing undertaken across 12 
countries (14 sites) during 2000. The final results suggest that these measures have 
acceptable measurement properties for use in many settings and in different languages, and are 
suitable for national population-based prevalence studies of participation in physical activity. 
 
Using IPAQ 
Use of the IPAQ instruments for monitoring and research purposes is encouraged. It is 
recommended that no changes be made to the order or wording of the questions as this will 
affect the psychometric properties of the instruments. 
 
Translation from English and Cultural Adaptation 
Translation from English is supported to facilitate worldwide use of IPAQ. Information on 
the availability of IPAQ in different languages can be obtained at  www.ipaq.ki.se. If a new 
translation is undertaken we highly recommend using the prescribed back translation methods 
available on the IPAQ website. If possible please consider making your translated version of 
IPAQ available to others by contributing it to the IPAQ website. Further details on translation 
and cultural adaptation can be downloaded from the website. 
 
Further Developments of IPAQ 
International collaboration on IPAQ is on-going and an International Physical Activity 
Prevalence Study is in progress. For further information see the IPAQ website. 
 
More Information 
More detailed information on the IPAQ process and the research methods used in the 
development of IPAQ instruments is available at  www.ipaq.ki.se and Booth, M.L. (2000). 
Assessment of Physical Activity: An International Perspective.  Research Quarterly for Exercise 
and Sport, 71 (2): s114-20.  Other scientific publications and presentations on the use of IPAQ 
are summarized on the website. 
SHORT LAST 7 DAYS SELF-ADMINISTERED version of the IPAQ.  Revised August 2002.  
INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE 
 
We are interested in finding out about the kinds of physical activities that people do as part of 
their everyday lives.  The questions will ask you about the time you spent being physically 
active in the  last 7 days.  Please answer each question even if you do not consider yourself to be 
an active person.  Please think about the activities you do at work, as part of your house and yard 
work, to get from place to place, and in your spare time for recreation, exercise or sport. 
 
Think about all the vigorous activities that you did in the last 7 days.  Vigorous physical 
activities refer to activities that take hard physical effort and make you breathe much harder 
than normal. Think only about those physical activities that you did for at least 10 minutes at a 
time. 
 
1. During the last 7 days, on how many days did you do vigorous physical 
activities like heavy lifting, digging, aerobics, or fast bicycling? 
 
  days per week 
 
No vigorous physical activities Skip to question 3 
 
 
2. How much time did you usually spend doing vigorous physical activities on one of those 
days? 
 
  hours per day 
 
  minutes per day 
 
 
Don’t know/Not sure 
 
 
Think about all the moderate activities that you did in the last 7 days.  Moderate activities 
refer to activities that take moderate physical effort and make you breathe somewhat harder 
than normal. Think only about those physical activities that you did for at least 10 minutes at 
a time. 
 
 
 
3. During the last 7 days, on how many days did you do moderate physical activities like 
carrying light loads, bicycling at a regular pace, or doubles tennis? Do not include 
walking. 
 
  days per week 
 
No moderate physical activities Skip to question 5 
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4. How much time did you usually spend doing moderate physical activities on one of 
those days? 
 
  hours per day 
 
  minutes per day 
 
 
Don’t know/Not sure 
 
 
 
Think about the time you spent walking in the last 7 days.  This includes at work and at home, 
walking to travel from place to place, and any other walking that you might do solely for 
recreation, sport, exercise, or leisure. 
 
5. During the last 7 days, on how many days did you walk for at least 10 minutes at a 
time? 
 
  days per week 
 
No walking  Skip to question 7 
 
 
 
6. How much time did you usually spend walking on one of those days? 
 
  hours per day 
 
  minutes per day 
 
 
Don’t know/Not sure 
 
 
The last question is about the time you spent sitting on weekdays during the last 7 days.  
Include time spent at work, at home, while doing course work and during leisure time. This 
may include time spent sitting at a desk, visiting friends, reading, or sitting or lying down to 
watch television. 
 
7.  During the last 7 days, how much time did you spend sitting on a week day? 
 
  hours per day 
 
  minutes per day 
 
 
Don’t know/Not sure 
 
 
This is the end of the questionnaire, thank you for participating. 
 
 2002منقحة أغسطس  -الصيغة المختصرة الستبانة النشاط البدني الدولية، لالستخدام عن طريق الهاتف
 (2002 أغسطس)                 ستبانة النشاط البدني الدوليةا
 سنة( 96-51والكبار للشباب ماضية )ال ةلقياس مستوى النشاط البدني في األيام السبع    
 لالستبانة، لالستخدام بواسطة الهاتفة المختصر صيغةال  
 ــــــــــــــــــــــــــــــــــــــــــــــــــــــــ
حقنو  مسنتقلة منن  1أربع مجموعات من االستبانات؛ صيغة مطولة )تتكون منن  (IPAQ) استبانة النشاط البدني الدولية تتضمن
لالسنتخدام بواسنطة  حنداااإن، ا(. لكل صنيغة منن الصنيغتين اسنتبانتعامة بنود 4األنشطة البدنية(، وصيغة مختصرة )مكونة من 
إن ادف انذ  االسنتبانات انو تنوفير أداة مشنتركة يمكنن ئتها من قبل الشخص نفسه(. الهاتف، واألخرى لالستخدام الذاتي )يتم تعب
 من خال  استخدامها الحصو  على بيانات عن مستوى النشاط البدني المرتبط بالصحة، قابلة للمقارنة دولياً.
 خلفية عن استبانة النشاط البدني الدولية
بنارات مكففنة إجنراء اخت م2000في عام  م، وتبع ذلك5661ينة جنيف في عام للنشاط البدني في مد بدأت عملية بناء مقياس دولي
موقعاً(. ولقد أظهرت النتائج النهائية أن المقناييس المسنتخدمة تمتناخ بخنواا قيناس  54دولة ) 52، شملت لصدق المقياس وثباته
لدراسنات الوطنينة لمعرفنة شنيوا ممارسنة صنالحيتها لالسنتعما  فني امنع الستخدامها في أماكن متعددة وبلغات مختلفة،  ،مقبولة
 النشاط البدني لدى السكان.
  استبانة النشاط البدني الدولية ستخداما
وصني بعندم إحندا  يلبحنث العلمني. ولغنر امراقبة مستوى النشاط البدني، ول م استبانة النشاط البدني الدوليةاستخدا على يُحث
 ستخدمة، ألن ذلك يؤثر في الخصائص السيكومترية لألداة.أي تغيير في ترتيب األسئلة أو في الكلمات الم
 مة الفقافيةءالترجمة من اللغة اإلنجليزية والمال
يسهل استعمالها على نطناق  مما، يستحق التأييدأمر إن ترجمة استبانة النشاط البدني الدولية من اللغة اإلنجليزية إلى لغات أخرى 
علقننة بتننوفر االسننتبانة الدوليننة للنشنناط البنندني بلغننات مختلفننة مننن الموقننع التننالي  واسننع. ويمكننن الحصننو  علننى المعلومننات المت
www.ipaq.ki.se طريقنة الترجمنة العكسننية  ، وفني حالنة الشنروا فني ترجمننة االسنتبانة، فدنننا نوصني بشندة أن يننتم اسنتخدام
(Back translationإتاحنة النسنخة  ضنع فني االعتبنار السنتبانة اإللكترونني. فضنالً، إذا كنان ممكنناً،( الموضنحة علنى موقنع ا
لومنات إضنافية حنو  المترجمة من االستبانة الدولية لآلخرين، وذلك بوضعها في الموقنع اإللكترونني، ويمكنن الحصنو  علنى مع
 النشاط البدني الدولية. مة الفقافية من خال  موقع استبانةالترجمة والمالء
   البيانات وترميزااإدخا
ملحق مع إجابات كل سؤا  من أسئلة استبانة النشاط البدني الدولية رموخ مقترحة للمتغيرات والمدى المتوقنع لججابنات، لتسنهيل 
 بالضنبط وصني بنأن ينتموي ،القنائمين علنى إجنراء المقنابالت عملية إدخا  البيانات والتعامنل معهنا، وللمسناعدة فني عملينة تندريب
فني خاننة الندقائق، وفني حالنة اإلجابنة بسناعتين،  520دقيقنة   تكتنب  520جابة الفعلية للمجيب، فعلى سنبيل المفنا     تسجيل اإل
فني  00السناعات، و  دفني عنامو 5في خانة الساعات، أما في حالة كون اإلجابة   ساعة ونصف   فتكتنب علنى أسناس  2فتكتب 
 الدقائق.  دعامو
 الدولية استبانة النشاط البدني تطورات
إن التعاون الدولي حو  استبانة النشاط البدني الدولية مستمر، وحالياً يتم إنجاخ دراسة دولية حو  شيوا ممارسة النشناط البندني. 
 ولمزيد من المعلومات، يمكن الرجوا إلى الموقع اإللكتروني الستبانة النشاط البدني الدولية.
 معلومات إضافية
معلومات إضافية حو  إجراءات استبانة النشاط البدني الدولية وطرق   www.ipaq.ki.seني التالي  يتوافر في الموقع اإللكترو
 Booth, M. L. (2000). Assessment of Physical Activity: Anيمكنن الرجنوا للمرجنع التنالي  و ،هنائالبحنث المسنتخدمة فني بنا
International Perspective. Research Quarterly for Exercise and Sport, 71 (2): s 114-20.                                فر، كمنا يتنو
لبحو  أخرى نشرت أو ألقيت في مؤتمرات علمية، حو  استخدام استبانة النشاط البندني  على الموقع اإللكتروني، عر موجز
 الدولية.
 
 لالستخدام بواسطة الهاتف ،النشاط البدني الدولية انةالستبة المختصر صيغةال  
 ـــــــــــــــــــــــــــــــــــــــــــــــ
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أنشنطة بدنينة خنال  األينام  قضنيته فني ممارسنةسنوف أسنألك بعنأل األسنئلة عنن الوقنت النذي    أقرأ على المشارك
ط بندنياً. فكنر فني ينفسنك غينر نشن تبنرن كننت تعكل سؤا  من األسنئلة التالينة حتنى وإ نالماضية. فضالً أجب ع ةالسبع
تلنك التني و اء تنقلنك منن مكنان ،خنر، ننث، و أأعمالنك المنزلينةكجزء منن و خال  عملك، األنشطة البدنية التي تمارسها
 .تقوم بها في وقت فراغك بغر الترويح أو التمرين أو الرياضة
قمنت بممارسنتها التي تتطلب جهداً بدنياً مرتفع الشدة والتي ا،ن فكر في جميع األنشطة البدنية    أقرأ على المشارك
، أعلى بكفير من المعتادمرتفعة الشدة اي تلك األنشطة التي تجعل تنفسك الماضية. األنشطة البدنية  ةخال  األيام السبع
 كنرة لقندم، أو، أو الجنري، أو ممارسنة كنرة امفل رفع أشياء ثقيلة، أو حر  األر ، أو ركوب الدراجة بسرعة عالية
علنى  دقنائق 50مرتفعة الشدة التي قمت بممارستها لمدة فكر فقط في األنشطة البدنية   .، أو السباحة، أو نط الحبلالسلة
  في كل مرة. قلاأل
ً ، كم يومالماضية ةاأليام السبعخال   -5  مارست فيه نشاطاً بدنياً مرتفع الشدة؟ ا
 [VDAY; Range 0-7, 8, 9]  ........ يوم في األسبوا 
 دري/ أو غير متأكديال    8. 
 رفأل اإلجابة   9. 
 50دة مرتفعنة الشندة التني قمنت بممارسنتها لمنفقنط فني األنشنطة البدنينة    فكنرمجري المقابلةإيضاح من ) 
 في كل مرة(. على األقل دقائق
 بننة عنننأو رفننأل اإلجا، ( انني صننفر5  إذا كانننت اإلجابننة عننن السننؤا  رقننم )لمجننري المقابلننةملحوظننة ) 
 (.0نتقل مباشرة إلى السؤا  رقم اأو لم يعرف الجواب،  ،السؤا 
ً قضيته في كل يوم مارست فيه نشاطمن الوقت  في المعتاد، كم -2 ً بدني ا    مرتفع الشدة؟ ا
 ]Range 0HRSVD ;-16[  ساعة في اليوم   --  -- 
 ]Range 0MINVD ;-960, 998, 999[دقيقة في اليوم    -- -- -- 
 ال أدري/ أو غير متأكد    998. 
 رفأل اإلجابة    999. 
 50دة مرتفعنة الشندة التني قمنت بممارسنتها لمنفقنط فني األنشنطة البدنينة    فكنرمجري المقابلةإيضاح من ) 
 في كل مرة(. على األقل دقائق
ً   مجري المقابلةمن  متابعة)   مرتفنع  المطلوب او متوسط الوقت ألحد األيام التي مارست فيها نشاطاً بندنيا
  كنم هألن وقت الممارسة تفاوت كفيراً من يوم ،خر، أسنأل ،السؤا  ا لم يتمكن المجيب من اإلجابة عنالشدة. إذ
 (.مرتفع الشدة؟ بدني في ممارسة نشاط الماضية عةاأليام السبمجموا الوقت الذي قضيته خال  
 ]Range 0HRSWV ;-121[  األسبواساعة في    --  --     
 ]Range 0MINWV ;-6720, 9899, 9999[  األسبوادقيقة في   -- -- -- 
 2002منقحة أغسطس  -الصيغة المختصرة الستبانة النشاط البدني الدولية، لالستخدام عن طريق الهاتف
 دري/ أو غير متأكديال    9998. 
 رفأل اإلجابة   9999. 
قمنت بممارسنتها ا،ن فكر في جميع األنشطة البدنية التي تتطلب جهداً بدنياً معتد  الشدة والتي    أقرأ على المشارك
إلنى  أعلنى منن المعتنادالشدة اي تلك األنشنطة التني تجعنل تنفسنك  معتدلةة الماضية. األنشطة البدني ةخال  األيام السبع
، أو ممارسنة ممارسنة كنرة الطنائرة، أو عادية، أو ركوب الدراجة بسرعة خفيفةرفع أشياء  ويمكن أن تتضمن، حداً ما
ً  ،أو كنس المنز ، تنس الطاولة   األنشنطة. منرة ال تحسنب المشني ضنمن انذ .، أو غسل السيارةأو غسل المالبس يدويا
 في كل مرة.  على األقل دقائق 50ة الشدة التي قمت بممارستها لمدة معتدلفكر فقط في األنشطة البدنية  أخرى،
 ، كم يوماً مارست فيه نشاطاً بدنياً معتد  الشدة؟الماضية ةاأليام السبعخال   -0
 [MDAY; Range 0-7, 8, 9]........ يوم في األسبوا   
 و غير متأكددري/ أيال    8. 
 رفأل اإلجابة   9. 
 50دة الشندة التني قمنت بممارسنتها لمن معتدلنةفقنط فني األنشنطة البدنينة    فكنرمجري المقابلنةإيضاح من ) 
 دقائق على األقل في كل مرة(.
 ( انني صننفر، أو رفننأل اإلجابننة عننن0السننؤا  رقننم ) ابننة عننن  إذا كانننت اإلجلمجننري المقابلننةملحوظننة ) 
 (.1نتقل مباشرة إلى السؤا  رقم االجواب، أو لم يعرف  ،السؤا 
ً مارست فيه نشاط كل يومقضيته في  في المعتاد، كم من الوقت -4 ً بدني ا  معتد  الشدة؟   ا
 ]Range 0MDHRS ;-16[ساعة في اليوم     --  -- 
 ]Range 0MDMIN ;-960, 998, 999[دقيقة في اليوم    -- -- -- 
 دري/ أو غير متأكديال     998. 
 رفأل اإلجابة    999. 
 50دة ة الشندة التني قمنت بممارسنتها لمنمعتدلنفقنط فني األنشنطة البدنينة    فكنرمجري المقابلنةإيضاح من ) 
 دقائق على األقل في كل مرة(.
  المطلوب او متوسط الوقت ألحد األيام التي مارست فيهنا نشناطاً بندنياً معتند  مجري المقابلةمن  متابعة) 
  كنم هأسنألالسؤا  ألن وقت الممارسة تفاوت كفيراً منن ينوم ،خنر،  نالمجيب من اإلجابة ع الشدة. إذا لم يتمكن
 بدني معتد  الشدة؟(. في ممارسة نشاط الماضية ةاأليام السبعمجموا الوقت الذي قضيته خال  
 ]Range 0MWHRS ;-112[  األسبوا ساعة في   --  -- 
 ]RangeMWMIN ; 0-6720, 9998, 9999[ األسبوادقيقة في   -- -- -- 
 دري/ أو غير متأكديال    9998. 
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 رفأل اإلجابة   9999. 
خال  األيام السبع الماضية، ويتضنمن ذلنك المشني  المشي في ا،ن فكر في الوقت الذي قضيته   أقرأ على المشارك
أننواا المشني بغنر  إلى العمل، والمشي أثناء العمنل، وفني البينت، وخنال  انتقالنك منن مكنان ،خنر، أو أي ننوا منن
 . الترويح أو الرياضة
 ؟دقائق على األقل في كل مرة 50المشي لمدة ، كم يوماً مارست فيه الماضية ةاأليام السبعخال   -1
 [WDAY; Range 0-7, 8, 9]........ يوم في األسبوا   
 دري/ أو غير متأكديال    8. 
 رفأل اإلجابة   9. 
 دقائق على األقل في كل مرة(. 50دة لم هقمت ب المشي الذيفي فقط    فكرالمقابلة مجري إيضاح من)
 ،السنؤا  ( اي صفر، أو رفنأل اإلجابنة عنن1السؤا  رقم ) ن  إذا كانت اإلجابة علمجري المقابلةملحوظة ) 
 (.7أو لم يعرف الجواب، أنتقل مباشرة إلى السؤا  رقم 
 ؟  ي المش ت فيهمارسكل يوم في المعتاد، كم من الوقت قضيته في  -9
 ]Range 0DHRSW ;-16[ساعة في اليوم     --  -- 
 ]Range 0DMINW ;-960, 998, 999[دقيقة في اليوم    -- -- -- 
 دري/ أو غير متأكديال     998. 
 رفأل اإلجابة    999. 
    ذا لنم . إالمشني  المطلنوب انو متوسنط الوقنت ألحند األينام التني مارسنت فيهنا مجنري المقابلنةمنن  متابعنة) 
كنم مجمنوا   هالسنؤا  ألن وقنت الممارسنة تفناوت كفينراً منن ينوم ،خنر، أسنأل يتمكن المجينب منن اإلجابنة عنن
 ؟(. الماضية ةاأليام السبعخال   في المشي الوقت الذي قضيته
 ]Range 0HRSWW ;-112[  األسبوا ساعة في  -- --  -- 
 ]Range 0MINWW ;-6720, 9989, 9999[  األسبوادقيقة في   -- -- -- -- 
 دري/ أو غير متأكديال      9998. 
 رفأل اإلجابة     9999. 
ً ا،ن فكر في الوقت الذي قضيته    أقرأ على المشارك أحسب وقت الجلنوس فني الماضية.  ةخال  األيام السبع جالسا
وأثناء العمنل  تب،الجلوس على المكوقت ن يتضمن ذلك العمل، وفي المنز ، وفي الدراسة، وفي الترفيه. من الممكن أ
 .لمشاادة التلفزيون ءأو االستلقا و الجلوسو أثناء خيارتك لصديق، و أثناء القراءة،  على الكمبيوتر،
ً  ، كم من الوقت قضيتهالماضية ةاأليام السبعخال   -7  ؟أيام اإلجاخة األسبوعية غيرمن  أحد اذ  األيام في جالسا
 2002منقحة أغسطس  -الصيغة المختصرة الستبانة النشاط البدني الدولية، لالستخدام عن طريق الهاتف
 ]Range 0HRSDS ;-16[ اليوم في ساعة   --  -- 
 ]Range 0MINSD ;-999 ,998 ,960[  اليومفي دقيقة   -- --  -- 
 دري/ أو غير متأكديال     998. 
 رفأل اإلجابة    999. 
، وكنذلك وقنت مستلقياً وأننت مسنتيق  الوقت الذي كنت فيه ،ذلك ضمنيدخل   مجري المقابلةإيضاح من ) 
 الجلوس(.
ً ه تالذي قضي الواحد الوقت في اليوم المطلوب او متوسط  مجري المقابلة متابعة من)  . إذا لنم ينتمكن جالسا
كنم مجمنوا الوقنت النذي   هالسؤا  ألن وقت الجلوس يتفاوت كفيراً من يوم ،خر، أسأل ناإلجابة ع المجيب من
 قضيته جالساً في يوم االثنين الماضي؟(.
 ]Range 0HRSWS ;-16[ساعة في يوم األثنين     --  -- 
 ]Range 0MINWS ;-999 ,998 ,960[قة في يوم األثنين  دقي  -- --  -- 
 دري/ أو غير متأكديال     998. 
 رفأل اإلجابة     999. 
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1. Introduction 
 
This document describes recommended methods of scoring the data derived from the 
telephone / interview administered and self-administered IPAQ short and long form 
instruments. The methods outlined provide a revision to earlier scoring protocols for the IPAQ 
short form and provide for the first time a comparable scoring method 
for IPAQ long form. Latest versions of IPAQ instruments are available from 
www.ipaq.ki.se. 
 
Although there are many different ways to analyse physical activity data, to date 
there is no formal consensus on a ‘correct’ method for defining or describing levels of 
physical activity based on self–report population surveys. The use of different scoring 
protocols makes it very difficult to compare within and between countries, even when the 
same instrument has been used. Use of these scoring methods will enhance the comparability 
between surveys, provided identical sampling and survey methods 
have been used. 
 
2. Uses of IPAQ Instruments 
 
IPAQ short form is an instrument designed primarily for population surveillance of 
physical activity among adults. It has been developed and tested for use in adults (age range 
of 15-69 years) and until further development and testing is undertaken the use of IPAQ 
with older and younger age groups is not recommended. 
 
IPAQ short and long forms are sometimes being used as an evaluation tool in intervention 
studies, but this was not the intended purpose of IPAQ. Users should carefully note the 
range of domains and types of activities included in IPAQ  before using it in this context. 
Use as an outcome measure in small scale intervention studies is not recommended. 
 
 
 
3. Summary Characteristics of IPAQ Short and Long Forms 
 
1. IPAQ assesses physical activity undertaken across a comprehensive set of domains 
including: 
a. leisure time physical activity 
b. domestic and gardening (yard) activities c.  
work-related physical activity 
d.  transport-related physical activity; 
 
2. The IPAQ short form asks about three specific types of activity undertaken in the four 
domains introduced above. The specific types of activity that are assessed are 
walking, moderate-intensity activities and vigorous-intensity activities. 
 
3. The items in the short IPAQ form were structured to provide separate scores on walking, 
moderate-intensity and vigorous-intensity activity. Computation of the total score for the 
short form requires summation of the duration (in minutes) 
and frequency (days) of walking, moderate-intensity and vigorous-intensity 
activities. Domain specific estimates cannot be estimated. 
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4. The IPAQ long form asks details about the specific types of activities undertaken 
within each of the four domains. Examples include walking for transportation and 
moderate-intensity leisure-time activity. 
 
5. The items in the long IPAQ form were structured to provide separate domain specific 
scores for walking, moderate-intensity and vigorous-intensity activity within each of the 
work, transportation, domestic chores and gardening (yard) and leisure-time domains. 
Computation of the total scores for the long form requires summation of the duration (in 
minutes) and frequency (days) for all the types of activities in all domains. Domain 
specific scores or activity specific sub- scores may be calculated. Domain specific scores 
require summation of the scores for walking, moderate-intensity and vigorous-intensity 
activities within the specific domain, whereas activity-specific scores require summation 
of the scores for the specific type of activity across domains. 
 
 
 
4. Overview of Continuous and Categorical Analyses of IPAQ 
 
Both categorical and continuous indicators of physical activity are possible from both IPAQ 
forms. However, given the non-normal distribution of energy expenditure in many 
populations, it is suggested that the continuous indicator be presented as median 
minutes/week or median MET–minutes/week rather than means (such as mean minutes/week 
or mean MET-minutes/week). 
 
 
 
4.1 Continuous Variables 
 
Data collected with IPAQ can be reported as a continuous measure. One measure of the 
volume of activity can be computed by weighting each type of activity by its energy 
requirements defined in METs to yield a score in MET–minutes. METs are multiples of the 
resting metabolic rate and a MET-minute is computed by multiplying the MET score of an 
activity by the minutes performed.  MET-minute scores are equivalent to kilocalories for a 60 
kilogram person. Kilocalories may be computed from MET-minutes using the following 
equation:  MET-min x (weight in kilograms/60 kilograms).  MET-minutes/day or MET-
minutes/week can be presented although the latter is more frequently used and is thus 
suggested. 
 
Details for the computation for summary variables from IPAQ short and long forms are 
detailed below. As there are no established thresholds for presenting MET- minutes, the 
IPAQ Research Committee propose that these data are reported as comparisons of median 
values and interquartile ranges for different populations. 
 
4.2 Categorical Variable: Rationale for Cut Point Values 
 
There are three levels of physical activity proposed to classify populations: 
1.  Low 
2.  Moderate 
3.  High 
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The algorithms for the short and long forms are defined in more detail in Sections 5.3 and 6.3, 
respectively. Rules for data cleaning and processing prior to computing the algorithms appear 
in Section 7. 
 
Regular participation is a key concept included in current public health guidelines for physical 
activity.
1 
Therefore, both the total volume and the number of days/sessions are included in the 
IPAQ analysis algorithms. 
 
The criteria for these levels have been set taking into account that IPAQ asks questions in all 
domains of daily life, resulting in higher median MET-minutes estimates than would have 
been estimated from leisure-time participation alone. The criteria for these three levels are 
shown below. 
 
Given that measures such as IPAQ assess total physical activity in all domains, the “leisure 
time physical activity” based public health recommendation of 30 minutes on most days will 
be achieved by most adults in a population. Although widely accepted as a goal, in absolute 
terms 30 minutes of moderate-intensity activity is low and broadly equivalent to the 
background or basal levels of activity adult individuals would accumulate in a day. Therefore 
a new, higher cutpoint is needed to describe the levels of physical activity associated with 
health benefits for measures such as IPAQ, which  report on a broad range of domains of 
physical activity. 
 
 
‘High’ 
 
This category was developed to describe higher levels of participation. Although it is known 
that greater health benefits are associated with increased levels of activity there is no 
consensus on the exact amount of activity for maximal benefit. In the absence of any 
established criteria, the IPAQ Research Committee proposes a measure which equates to 
approximately at least one hour per day or more, of at 
least moderate-intensity activity above the basal level of physical activity Considering that 
basal activity may be considered to be equivalent to approximately 5000 steps per day, it is  
proposed that “high active” category be considered as those who move at least 12,500 steps 
per day, or the equivalent in moderate and vigorous activities. This represents at least an hour 
more moderate-intensity activity over and above the basal level of activity, or half an hour of 
vigorous-intensity activity over and above basal levels daily. These calculations were based on 
emerging results of pedometers 
studies.
2
 
 
This category provides a higher threshold of measures of total physical activity and is a useful 
mechanism to distinguish variation in population groups. Also it could be used to set 
population targets  for health-enhancing physical activity when multi- domain instruments, 
such as IPAQ are used. 
 
 
1 
Pate RR, Pratt M, Blair SN, Haskell WL , Macera CA, Bouchard C et al. Physical activity and public health. A 
recommendation from the Centers for Disease Control and Prevention and the American College of Sports 
Medicine. Journal of American 
Medical Association 1995; 273(5):402-7. and U.S. Department of Health and Human Services. Physical Activity 
and Health: A 
Report of the Surgeon General. Department of Health and Human Services, Centers for Disease Control and 
Prevention, National Center for Chronic Disease Prevention and Health Promotion, The Presidents' Council on 
Physical Fitness and Sports: Atlanta, GA:USA. 1996. 
2 Tudor-Locke C, Bassett DR Jr. How many steps/day are enough? Preliminary pedometer indices for public 
health. Sports 
Med. 2004;34(1):1-8. 
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 ‘Moderate’ 
 
This category is defined as doing some activity, more than the low active category. It is 
proposed that it is a level of activity equivalent to “half an hour of at least 
moderate-intensity PA on most days”, the former leisure time-based physical activity 
population health recommendation. 
 
‘Low’ 
 
This category is simply defined as not meeting any of the criteria for either of the 
previous categories. 
 
 
 
5. Protocol for IPAQ Short Form 
 
5.1 Continuous Scores 
 
Median values and interquartile ranges can be computed for walking (W), moderate- intensity 
activities (M), vigorous-intensity activities (V) and a combined total physical activity score. 
All continuous scores are expressed in MET-minutes/week as defined below. 
 
5.2 MET Values and Formula for Computation of MET-minutes/week 
 
The selected MET values were derived from work undertaken during the IPAQ Reliability 
Study undertaken in 2000-2001
3
. Using the Ainsworth et al. Compendium (Med Sci Sports 
Med 2000) an average MET score was derived for each type of activity. For example; all 
types of walking were included and an average MET value for walking was created. The same 
procedure was undertaken for moderate-intensity 
activities and vigorous-intensity activities. The following values continue to be used for the 
analysis of IPAQ data: Walking = 3.3 METs, Moderate PA = 4.0 METs and Vigorous PA = 
8.0 METs. Using these values, four continuous scores are defined: 
 
Walking MET-minutes/week = 3.3 * walking minutes * walking days 
Moderate MET-minutes/week = 4.0 * moderate-intensity activity minutes * moderate 
days Vigorous MET-minutes/week = 8.0 * vigorous-intensity activity minutes * 
vigorous-intensity days Total physical activity MET-minutes/week = sum of Walking + 
Moderate + Vigorous MET- minutes/week scores. 
 
 
 
5.3 Categorical Score 
 
Category 1 Low 
 
This is the lowest level of physical activity.  Those individuals who not meet criteria for 
Categories 2 or 3 are considered to have a ‘low’ physical activity level. 
 
 
 
 
3 
Craig CL,Marshall A , Sjostrom M et al. International Physical Activity Questionnaire: 12 country 
reliability and validity Med Sci Sports Exerc 2003;August 
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Category 2 Moderate 
 
The pattern of activity to be classified as ‘moderate’ is either of the following criteria: 
a)  3 or more days of vigorous-intensity activity of at least 20 minutes per day 
OR 
b)  5 or more days of moderate-intensity activity and/or walking of at least 30 
minutes per day 
OR 
c)  5 or more days of any combination of walking, moderate-intensity or vigorous 
intensity activities achieving a minimum Total physical activity of at least 600 
MET-minutes/week. 
 
 
 
Individuals meeting at least one of the above criteria would be defined as accumulating a 
minimum level of activity and therefore be classified as ‘moderate’. See Section 7.5 for 
information about combining days across categories. 
 
Category 3 High 
 
A separate category labelled ‘high’ can be computed to describe higher levels of 
participation. 
The two criteria for classification as ‘high’ are: 
a) vigorous-intensity activity on at least 3 days achieving a minimum Total 
physical activity of at least 1500 MET-minutes/week 
OR 
b) 7 or more days of any combination of walking, moderate-intensity or 
vigorous-intensity activities achieving a minimum Total physical activity 
of at least 3000 MET-minutes/week. 
 
See Section 7.5 for information about combining days across categories. 
 
 
 
5.4 Sitting Question in IPAQ Short Form 
 
The IPAQ sitting question is an additional indicator variable of time spent in sedentary activity 
and is not included as part of any summary score of physical activity. Data on sitting should be 
reported as median values and interquartile ranges. To-date there are few data on sedentary 
(sitting) behaviours and no well-accepted thresholds for data presented as categorical levels. 
 
 
 
6. Protocol for IPAQ Long Form 
 
The long form of IPAQ asks in detail about walking, moderate-intensity and vigorous- 
intensity physical activity in each of the four domains. Note: asking more detailed questions 
regarding physical activity within domains is likely to produce higher prevalence estimates 
than the more generic IPAQ short form. 
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6.1 Continuous Score 
 
Data collected with the IPAQ long form can be reported as a continuous measure and 
reported as median MET-minutes. Median values and interquartile ranges can 
be computed for walking (W), moderate-intensity activities (M), and vigorous-intensity 
activities (V) within each domain using the formulas below. Total scores may also be 
calculated for walking (W), moderate-intensity activities (M), and vigorous-intensity activities 
(V); for each domain (work, transport, domestic and garden, and leisure) 
and for an overall grand total. 
 
 
 
6.2 MET Values and Formula for Computation of MET-minutes 
 
Work Domain 
Walking MET-minutes/week at work = 3.3 * walking minutes * walking days at work 
Moderate MET-minutes/week at work= 4.0 * moderate-intensity activity minutes * 
moderate-intensity days at work 
Vigorous MET-minutes/week at work= 8.0 * vigorous-intensity activity minutes * 
vigorous-intensity days at work 
Total Work MET-minutes/week =sum of Walking + Moderate + Vigorous MET-
minutes/week scores at work. 
 
Active Transportation Domain 
Walking MET-minutes/week for transport = 3.3 * walking minutes * walking days for 
transportation 
Cycle MET-minutes/week for transport= 6.0 * cycling minutes * cycle days for transportation 
Total Transport MET-minutes/week = sum of Walking + Cycling MET-minutes/week 
scores for transportation. 
 
Domestic and Garden [Yard Work] Domain 
Vigorous MET-minutes/week yard chores= 5.5 * vigorous-intensity activity minutes * 
vigorous-intensity days doing yard work (Note: the MET value of 5.5 indicates that 
vigorous garden/yard work should be considered a moderate-intensity activity for scoring 
and computing total moderate intensity activities.) 
Moderate MET-minutes/week yard chores= 4.0 * moderate-intensity activity minutes * 
moderate- intensity days doing yard work 
Moderate MET-minutes/week inside chores= 3.0* moderate-intensity activity minutes * 
moderate- intensity days doing inside chores. 
Total Domestic and Garden MET-minutes/week =sum of Vigorous yard + Moderate yard + 
Moderate inside chores MET-minutes/week scores. 
 
Leisure-Time Domain 
Walking MET-minutes/week leisure = 3.3 * walking minutes * walking days in leisure 
Moderate MET-minutes/week leisure = 4.0 * moderate-intensity activity minutes * 
moderate-intensity days in leisure 
Vigorous MET-minutes/week leisure = 8.0 * vigorous-intensity activity minutes * 
vigorous-intensity days in leisure 
Total Leisure-Time MET-minutes/week = sum of Walking + Moderate + Vigorous MET-
minutes/week scores in leisure. 
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Total Scores for all Walking, Moderate and Vigorous Physical Activities 
Total Walking MET-minutes/week = Walking MET-minutes/week (at Work + for Transport + in Leisure) Total 
Moderate MET-minutes/week total = Moderate MET-minutes/week (at Work + Yard chores + 
inside chores + in Leisure time) + Cycling Met-minutes/week for Transport + Vigorous Yard chores 
MET-minutes/week 
Total Vigorous MET-minutes/week = Vigorous MET-minutes/week (at Work + in Leisure) 
 
Note: Cycling MET value and Vigorous garden/yard work MET value fall within the coding range of 
moderate-intensity activities. 
 
Total Physical Activity Scores 
 
An overall total physical activity MET-minutes/week score can be computed as: 
Total physical activity MET-minutes/week = sum of Total (Walking + Moderate + Vigorous) MET- 
minutes/week scores. 
This is equivalent to computing: 
Total physical activity MET-minutes/week = sum of Total Work + Total Transport + Total Domestic and 
Garden + Total Leisure-Time MET-minutes/week scores. 
 
As there are no established thresholds for presenting MET-minutes, the IPAQ Research Committee 
proposes that these data are reported as comparisons of median values and interquartile ranges for 
different populations. 
 
 
6.3 Categorical Score 
 
As noted earlier, regular participation is a key concept included in current public health 
guidelines for physical activity.
4 
Therefore, both the total volume and the number of 
day/sessions are included in the IPAQ analysis algorithms. There are three levels of physical 
activity proposed to classify populations – ‘low’,  ’moderate’, 
and ‘high’. The criteria for these levels are the same as for the IPAQ short [described earlier 
in Section 4.2] 
 
Category 1 Low 
 
This is the lowest level of physical activity.  Those individuals who not meet criteria for 
Categories 2 or 3 are considered ‘low’. 
 
Category 2 Moderate 
 
The pattern of activity to be classified as ‘moderate’ is either of the following criteria: 
d)  3 or more days of vigorous-intensity activity of at least 20 minutes per day 
OR 
e)  5 or more days of moderate-intensity activity and/or walking of at least 30 
minutes per day 
OR 
 
 
 
 
4 
Pate RR, Pratt M, Blair SN, Haskell WL , Macera CA, Bouchard C et al. Physical activity and public health. A 
recommendation from the Centers for Disease Control and Prevention and the American College of Sports 
Medicine. Journal of American Medical Association 1995; 273(5):402-7. and U.S. Department of Health and 
Human Services. Physical Activity and Health: AReport of the Surgeon General. Department of Health and 
Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention 
and Health Promotion, The Presidents' Council on Physical Fitness and Sports: 
Atlanta, GA:USA. 1996.
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f) 5 or more days of any combination of walking, moderate-intensity or vigorous- 
intensity activities achieving a minimum Total physical activity of at least 600 
MET-minutes/week. 
 
Individuals meeting at least one of the above criteria would be defined as accumulating 
a moderate level of activity. See Section 7.5 for information about combining days 
across categories. 
 
Category 3 High 
 
A separate category labelled ‘high’ can be computed to describe higher levels of 
participation. 
The two criteria for classification as ‘high’ are: 
a) vigorous-intensity activity on at least 3 days achieving a minimum Total 
physical activity of at least 1500 MET-minutes/week 
OR 
b) 7 or more days of any combination of walking, moderate-intensity or 
vigorous-intensity activities achieving a minimum Total physical activity of at 
least 3000 MET-minutes/week. 
 
See Section 7.5 for information about combining days across categories. 
 
 
 
6.4 IPAQ Sitting Question IPAQ Long Form 
 
The IPAQ sitting question is an additional indicator variable and is not included as part of any 
summary score of physical activity. To-date there are few data on sedentary (sitting) 
behaviours and no well-accepted thresholds for data presented as categorical levels. For the 
sitting question ‘Minutes’ is used as the indicator to reflect time spent in sitting rather than 
MET-minutes which would suggest an estimate of energy expenditure. 
 
IPAQ long assesses an estimate of sitting on a typical weekday, weekend day and time 
spent sitting during travel (see transport domain questions). 
 
Summary sitting variables include 
 
Sitting Total Minutes/week = weekday sitting minutes* 5 weekdays + weekend day sitting 
minutes* 2 weekend days 
 
Average Sitting Total Minutes/day = (weekday sitting minutes* 5 weekdays + weekend 
day sitting minutes* 2 weekend days) / 7 
 
Note: The above calculation of ‘Sitting Total’ excludes time spent sitting during travel because the introduction 
in IPAQ long directs the responder to NOT include this component as it would have already been captured under 
the Transport section. If a summary sitting variable including time spent sitting for transport is required, it 
should be calculated by adding the time reported (travelling in a motor vehicle) under transport to the above 
formula. Care should be taken in reporting these alternate data to clearly distinguish the ‘total sitting’ variable 
from a ‘total sitting – including transport’ variable. 
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7. Data Processing Rules 
 
In addition to a standardized approach to computing categorical and continuous measures of 
physical activity, it is necessary to undertake standard methods for the cleaning and 
treatment of IPAQ datasets. The use of different approaches and rules would introduce 
variability and reduce the comparability of data. 
 
There are no established rules for data cleaning and processing on physical activity. Thus, to 
allow more accurate comparisons across studies IPAQ Research Committee has established 
and recommends the following guidelines: 
 
7.1 Data Cleaning 
 
 
I.  Any responses to duration (time) provided in the hours and minutes response option 
should be converted from hours and minutes into minutes. 
II.  To ensure that responses in ‘minutes’ were not entered in the ‘hours’ column by mistake 
during self-completion or during data entry process, values of ‘15’, ‘30’, 
‘45’, ‘60’ and ‘90’ in the ‘hours’ column should be converted to ‘15’, ‘30’, ‘45’, ‘60’ 
and ‘90’ minutes, respectively, in the minutes column. 
III.  In some cases duration (time) will be reported as weekly (not daily) e.g., VWHRS, 
VWMINS. These data should be converted into an average daily time by dividing by 7. 
IV.  If ‘don’t know’ or ‘refused ‘  or data are missing for time or days then that case is 
removed from analysis. 
 
 
Note: Both the number of days and daily time are required for the creation of 
categorical and continuous summary variables 
 
 
 
7.2 Maximum Values for Excluding Outliers 
 
This rule is to exclude data which are unreasonably high; these data are to be considered 
outliers and thus are excluded from analysis. All cases in which the sum total of all Walking, 
Moderate and Vigorous time variables is greater than 960 minutes (16 hours) should be 
excluded from the analysis. This assumes that on average an individual of 8 hours per day is 
spent sleeping. 
 
The ‘days’ variables can take the range 0-7 days, or 8, 9 (don’t know or refused); 
values greater than 9 should not be allowed and those cases excluded from analysis. 
 
 
 
7.3 Minimum Values for Duration of Activity 
 
Only values of 10 or more minutes of activity should be included in the calculation of 
summary scores. The rationale being that the scientific evidence indicates that episodes or 
bouts of at least 10 minutes are required to achieve health benefits. Responses of less than 10 
minutes [and their associated days] should be re-coded to 
‘zero’. 
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7.4 Truncation of Data Rules 
 
This rule attempts to normalize the distribution of levels of activity which are usually 
skewed in national or large population data sets. 
 
In IPAQ short - it is recommended that all Walking, Moderate and Vigorous time variables 
exceeding ‘ 3 hours’ or ‘180 minutes’ are truncated (that is re-coded) to be equal to ‘180 
minutes’ in a new variable.  This rule permits a maximum of 21 hours of activity in a week to 
be reported for each category (3 hours * 7 days). 
 
In IPAQ long – the truncation process is more complicated, but to be consistent with the 
approach for IPAQ short requires that the variables total Walking, total Moderate- intensity 
and total Vigorous-intensity activity are calculated and then, for each of these summed 
behaviours, the total value should be truncated to 3 hours (180 minutes). 
 
When analysing the data as categorical variable or presenting median and interquartile ranges 
of the MET-minute scores, the application of the truncation rule will not affect the results. 
This rule does have the important effect of preventing misclassification in the ‘high’ category. 
For example, an individual who reports walking for 10 minutes on 6 days and 12 hours of 
moderate activity on one day could be coded as ‘high’ because this pattern meets the ‘7 day” 
and “3000 MET-min” criteria for ‘high’.  However, this uncommon pattern of activity is 
unlikely to yield the health benefits that the ‘high’ category is intended to represent. 
 
Although using median is recommended due to the skewed distribution of scores, if IPAQ 
data are analysed and presented  as a continuous variable using mean values, the application 
of the truncation rule will produce slightly lower mean values than would otherwise be 
obtained. 
 
 
 
7.5 Calculating MET-minute/week Scores 
 
Data processing rules 7.2, 7.3, and 7.4 deals first with excluding outlier data, then 
secondly, with recoding minimum values and then finally dealing with high values. These 
rules will ensure that highly active people remain classified as ‘high’, while decreasing the 
chances that less active individuals are misclassified and coded as 
‘high’. 
 
Using the resulting variables, convert time and days to MET-minute/week scores 
[see above Sections 5.2 and 6.2; METS x days x daily time]. 
 
 
 
7.6 Calculating Total Days for Presenting Categorical Data on Moderate and 
High Levels 
 
Presenting IPAQ data using categorical variables requires the total number of ‘days’ on which 
all physical activity was undertaken to be assessed. This is difficult because frequency in 
‘days’ is asked separately for walking, moderate-intensity and vigorous- intensity activities, 
thus allowing the total number of ‘days’ to range from a minimum 
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of 0 to a maximum of 21’days’ per week in IPAQ short and higher in IPAQ long. The IPAQ 
instrument does not record if different types of activity are undertaken on the same day. 
 
In calculating ‘moderately active’, the primary requirement is to identify those individuals 
who undertake activity on at least ‘5 days’/week [see Sections 4.2 and 
5.3]. Individuals who meet this criterion should be coded in a new variable called “at least 
five days” and this variable should be used to identify those meeting criterion b) at least 30 
minutes of moderate-intensity activity and/or walking; and those meeting criterion c) any 
combination of walking, moderate-intensity or vigorous-intensity activities achieving a 
minimum of 600 MET-minutes/week. 
 
Below are two examples showing this coding in practice: 
i) an individual who reports ‘2 days of moderate-intensity’ and ‘3 days of walking’ 
should be coded as a value indicating  “at least five days”; 
ii) an individual reporting ‘2 days of vigorous-intensity’, ‘2 days of moderate- 
intensity’ and ‘2 days of walking should be coded as a value to indicate  “at least 
five days” [even though the actual total is 6]. 
 
The original frequency of ‘days’ for each type of activity should remain in the data file for 
use in the other calculations. 
 
The same approach as described above is used to calculate total days for computing the ‘high’ 
category. The primary requirement according to the stated criteria is to identify those 
individuals who undertake a combination of walking, moderate-intensity and or vigorous-
intensity activity on at least 7 days/week  [See section 4.2]. 
Individuals who meet this criterion should be coded as a value in a new variable to reflect 
“at least 7 days”. 
 
Below are two examples showing this coding in practice: 
i) an individual who reports ‘4 days of moderate-intensity’ and ‘3 days of walking’ 
should be coded as the new variable “at least 7 days”. 
ii) an individual reporting ‘3 days of vigorous-intensity’, ‘3 days moderate- intensity’ 
and ‘3 days walking’  should be coded as “at least 7 days”  [even though the total 
adds to 9] . 
 
 
 
8. Summary algorithms 
 
The algorithms in Appendix 1 and Appendix 2 to this document show how these rules work in 
an analysis plan, to develop the categories 1 [Low], 2 [Moderate], and 3 
[High] levels of activity. 
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APPENDIX 1 
 
 
At A Glance 
IPAQ Scoring Protocol (Short Forms) 
 
Continuous Score 
 
Expressed as MET-min per week: MET level x minutes of activity/day x days per week 
 
Sample Calculation 
 
MET levels                                              MET-minutes/week for 30 min/day, 5 days 
Walking = 3.3 METs                                      3.3*30*5 =    495 MET-minutes/week Moderate Intensity 
= 4.0 METs                     4.0*30*5 =    600 MET-minutes/week Vigorous Intensity = 8.0 METs                      
8.0*30*5 = 1,200 MET-minutes/week 
 
TOTAL  =  2,295 MET-minutes/week 
 
Total MET-minutes/week = Walk (METs*min*days) + Mod (METs*min*days) + Vig 
(METs*min*days) 
 
 
 
Categorical Score- three levels of physical activity are proposed 
 
1. Low 
 
• No activity is reported OR 
• Some activity is reported but not enough to meet Categories 2 or 3. 
 
2. Moderate 
 
Either of the following 3 criteria 
• 3 or more days of vigorous activity of at least 20 minutes per day OR 
• 5 or more days of moderate-intensity activity and/or walking of at least 30 minutes per day OR 
• 5 or more days of any combination of walking, moderate-intensity or vigorous- intensity 
activities achieving a minimum of at least 600 MET-minutes/week. 
 
3. High 
 
Any one of the following 2 criteria 
• Vigorous-intensity activity on at least 3 days and accumulating at least 1500 
MET-minutes/week OR 
• 7 or more days of any combination of walking, moderate- or vigorous-intensity activities 
accumulating at least 3000 MET-minutes/week 
 
 
 
 
Please review the full document “Guidelines for the data processing and analysis of the International Physical 
Activity Questionnaire” for more detailed description of IPAQ analysis and recommendations for data cleaning 
and processing [www.ipaq.ki.se]. 
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APPENDIX 2 
 
 
At A Glance 
IPAQ Scoring Protocol (Long Forms) 
 
Continuous Score 
 
Expressed as MET-minutes per week: MET level x minutes of activity/day x days per week 
 
Sample Calculation 
 
MET levels                                              MET-minutes/week for 30 min/day, 5 days 
Walking at work= 3.3 METs                          3.3*30*5 =    495 MET-minutes/week Cycling for 
transportation= 6.0 METs            6.0*30*5 =    900 MET-minutes/week Moderate yard work= 4.0 
METs                    4.0*30*5 =    600 MET-minutes/week Vigorous intensity in leisure= 8.0 METs        
8.0*30*5 = 1,200 MET-minutes/week 
 
TOTAL  =  3,195 MET-minutes/week 
 
Domain Sub Scores 
Total MET-minutes/week at work = Walk (METs*min*days) + Mod (METs*min*days) + Vig 
(METs*min*days) at work 
 
Total MET-minutes/week for transportation = Walk (METs*min*days) + Cycle 
(METs*min*days) for transportation 
 
Total MET-minutes/week from domestic and garden = Vig (METs*min*days) yard work + Mod 
(METs*min*days) yard work + Mod (METs*min*days) inside chores 
 
Total MET-minutes/week in leisure-time = Walk (METs*min*days) + Mod (METs*min*days) 
+ Vig (METs*min*days) in leisure-time 
 
 
 
Walking, Moderate-Intensity and Vigorous-Intensity Sub Scores 
 
Total Walking MET-minutes/week = Walk MET-minutes/week (at Work + for Transport + in 
Leisure) 
 
Total Moderate MET-minutes/week = Cycle MET-minutes/week for Transport + Mod MET- minutes/week 
(Work + Yard chores + Inside chores + Leisure) + Vigorous Yard chores MET- minutes 
 
Note: The above is a total moderate activities only score. If you require a total of all moderate-intensity physical 
activities you would sum Total Walking and Total Moderate 
Total Vigorous MET-minutes/week = Vig MET-minutes/week (at Work + in Leisure) Total Physical 
Activity Score 
Total Physical Activity MET-minutes/week = Walking MET-minutes/week + Moderate MET- minutes/week + 
Total Vigorous MET-minutes/week 
 
Continued……….. 
 
Also 
 
Total Physical Activity MET-minutes/week = Total MET-minutes/week (at Work + for 
Transport + in Chores + in Leisure) 
 
 
 
Categorical Score- three levels of physical activity are proposed 
 
1.  Low 
 
No activity is reported OR 
a.  Some activity is reported but not enough to meet Categories 2 or 3. 
 
2.  Moderate 
 
Either of the following 3 criteria 
a.  3 or more days of vigorous-intensity activity of at least 20 minutes per day OR 
b.  5 or more days of moderate-intensity activity and/or walking of at least 30 minutes per day 
OR 
c.   5 or more days of any combination of walking, moderate-intensity or vigorous- intensity 
activities achieving a minimum of at least 600 MET-min/week. 
 
3.  High 
 
Any one of the following 2 criteria 
• Vigorous-intensity activity on at least 3 days and accumulating at least 1500 
MET-minutes/week OR 
• 7 or more days of any combination of walking, moderate- or vigorous- intensity activities 
accumulating at least 3000 MET-minutes/week 
 
 
 
 
 
Please review the full document “Guidelines for the data processing and analysis of the International Physical 
Activity Questionnaire” for more detailed description of IPAQ analysis and recommendations for data cleaning and 
processing [www.ipaq.ki.se]. 
 
Appendix D 
 
 
 
 
The range levels of Blood parameters 
 
 
Blood Parameter SI Units 
(International system) 
Traditional Units 
(USA) 
Glucose 3.3 – 5.8 mmol/L 59 – 105 mg/dL 
Insulin 36 – 179 pmol/L 5 – 25 µU/L 
Glucagon 50 – 200 ng/L 50 200 pg/mL 
Cortisol 
Time: am 
Time: pm 
nmol/L 
110 – 607 
83 – 469 
µg/dl 
5 – 25 
3.1 – 16.7 
Albumin 35 – 50 g/L 3.5 – 5.0 g/dL 
Total Protein 60 – 80 g/L 6.0 – 8.0 g/dL 
Total Cholesterol 
Desirable 
Borderline 
high 
mmol/L 
›5.2 
5.3 – 6.2 
‹ 6.2 
 
› 200 
201- 239 
‹ 240 
Triglycerides 
Desirable 
Borderline 
high 
mmol/L 
›5.2 
5.3 – 6.2 
‹ 6.2 
mg/dL 
› 150 
150- 199 
‹ 199 
Low density lipoprotein (LDL) 
Desirable 
Borderline 
high 
mmol/L 
›5.2 
5.3 – 6.2 
‹ 6.2 
mg/dL 
› 130 
130 – 159 
‹ 195 
High density lipoprotein  (HDL) 
Desirable 
Borderline 
high 
mmol/L 
›5.2 
5.3 – 6.2 
‹ 6.2 
mg/dL 
› 130 
130 – 159 
‹ 195 
Very low density lipoprotein 0.128 – 0.645 mmol/L 5 – 40 mg/dL 
 
 
